These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
ý
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
|
36-4459170
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(IRS Employer
Identification No.)
|
|
|
|
20 South Wacker Drive, Chicago, Illinois
|
|
60606
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Title Of Each Class
|
|
Name Of Each Exchange On Which Registered
|
Class A Common Stock $0.01 par value
|
|
NASDAQ GLOBAL SELECT MARKET
|
Large accelerated filer
x
|
|
|
|
Accelerated filer
o
|
|
|
|
|
|
Non-accelerated filer
o
|
|
(do not check if a smaller reporting company)
|
|
Smaller reporting company
o
|
Documents
|
|
Form 10-K Reference
|
Portions of the CME Group Inc.’s Proxy Statement for the 2012 Annual Meeting of Shareholders
|
|
Part III
|
|
|
|
Page
|
|
|
|
|
||
|
|
|
Item 1.
|
||
|
|
|
Item 1A.
|
||
|
|
|
Item 1B.
|
||
|
|
|
Item 2.
|
||
|
|
|
Item 3.
|
||
|
|
|
Item 4.
|
||
|
|
|
|
||
|
|
|
Item 5.
|
||
|
|
|
Item 6.
|
||
|
|
|
Item 7.
|
||
|
|
|
Item 7A.
|
||
|
|
|
Item 8.
|
||
|
|
|
Item 9.
|
||
|
|
|
Item 9A.
|
||
|
|
|
Item 9B.
|
||
|
|
|
|
||
|
|
|
Item 10.
|
||
|
|
|
Item 11.
|
||
|
|
|
Item 12.
|
||
|
|
|
Item 13.
|
||
|
|
|
Item 14.
|
||
|
|
|
|
||
|
|
|
Item 15.
|
||
|
|
|
|
•
|
increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities;
|
•
|
our ability to keep pace with rapid technological developments, including our ability to complete the development, implementation and maintenance of the enhanced functionality required by our customers;
|
•
|
our ability to continue introducing competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and our ability to maintain the competitiveness of our existing products and services, including our ability to provide effective services to the over-the-counter market;
|
•
|
our ability to adjust our fixed costs and expenses if our revenues decline;
|
•
|
our ability to maintain existing customers, develop strategic relationships and attract new customers, including end customers, intermediaries and clearing members;
|
•
|
our ability to expand and offer our products in non-U.S. jurisdictions;
|
•
|
changes in domestic and non-U.S. regulations;
|
•
|
changes in government policy, including policies relating to common or directed clearing, changes as a result of legislation and regulation stemming from the implementation of the Dodd-Frank Act or changes stemming from the bankruptcy of MF Global on our ability to use customer collateral;
|
•
|
the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others;
|
•
|
our ability to generate revenue from our market data that may be reduced or eliminated by the growth of electronic
|
•
|
changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure;
|
•
|
the ability of our financial safeguards package to adequately protect us from the credit risks of clearing members;
|
•
|
the ability of our compliance and risk management methods to effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual property assets;
|
•
|
changes in price levels and volatility in the derivatives markets and in underlying equity, foreign exchange, interest rate and commodities markets;
|
•
|
economic, political and market conditions, including the volatility of the capital and credit markets and the impact of economic conditions on the trading activity of our current and potential customers stemming from the financial crisis that began in 2008, the Eurozone debt crisis and any other future crises;
|
•
|
our ability to accommodate increases in trading volume and order transaction traffic without failure or degradation of the performance of our trading and clearing systems;
|
•
|
our ability to execute our growth strategy and maintain our growth effectively;
|
•
|
our ability to manage the risks and control the costs associated with our acquisition, investment and alliance strategy;
|
•
|
our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business;
|
•
|
industry and customer consolidation;
|
•
|
decreases in trading and clearing activity;
|
•
|
the imposition of a transaction tax or user fee on futures and options on futures transactions and/or repeal of the 60/40 tax treatment of such transactions;
|
•
|
the unfavorable resolution of material legal proceedings; and
|
•
|
the seasonality of the futures business.
|
ITEM 1.
|
BUSINESS
|
Product Line
|
|
2011
|
|
2010
|
|
2009
|
|||
Interest rate
|
|
27
|
%
|
|
27
|
%
|
|
26
|
%
|
Equity
|
|
21
|
|
|
21
|
|
|
24
|
|
Foreign exchange
|
|
7
|
|
|
7
|
|
|
6
|
|
Agricultural commodity
|
|
13
|
|
|
12
|
|
|
10
|
|
Energy
|
|
26
|
|
|
27
|
|
|
29
|
|
Metal
|
|
6
|
|
|
6
|
|
|
5
|
|
Trading Venue
|
|
2011
|
|
2010
|
|
2009
|
|||
Electronic
|
|
75
|
%
|
|
74
|
%
|
|
72
|
%
|
Open outcry
|
|
9
|
|
|
10
|
|
|
11
|
|
Privately negotiated
|
|
5
|
|
|
5
|
|
|
5
|
|
CME ClearPort (OTC)
|
|
11
|
|
|
11
|
|
|
12
|
|
•
|
certainty of execution;
|
•
|
vast capabilities to facilitate complex and demanding trading;
|
•
|
direct market access;
|
•
|
fairness, price transparency and anonymity; and
|
•
|
global distribution, including connection through high-speed international telecommunications hubs in key financial centers in Europe, Asia and Latin America.
|
•
|
depth and liquidity of markets;
|
•
|
transaction costs;
|
•
|
breadth of product offerings and rate and quality of new product development;
|
•
|
ability to position and expand upon existing products to address changing market needs;
|
•
|
transparency, reliability and anonymity in transaction processing;
|
•
|
connectivity, accessibility and distribution;
|
•
|
technological capability and innovation;
|
•
|
efficient and secure settlement, clearing and support services;
|
•
|
regulatory environment; and
|
•
|
reputation.
|
•
|
price transparency;
|
•
|
liquid markets to minimize transaction costs;
|
•
|
market integrity;
|
•
|
customer protection; and
|
•
|
the safety and soundness of central counterparty clearing services.
|
•
|
Changes to the core principles to designated contract markets, including any changes to Core Principle 9 -
the board of trade shall provide a competitive, open, and efficient market and mechanism for executing transactions that protects the price discovery process of trading in the centralized market of the board of trade
(Core Principle 9)
.
Rules promulgated under this provision may require us to make modifications to the manner in which certain of our contracts trade and/or require that such products be de-listed as futures and re-listed as swaps after a specified compliance period.
|
•
|
Changes to the self-regulatory model, which, if modified, could alter the manner in which we currently oversee our marketplace. We believe that we are best positioned to continue to conduct financial and market surveillance of our clearing firms.
|
•
|
The implementation of the position limit rules which could have a significant impact on our commodities business relative to such markets abroad given that it does not appear that foreign jurisdictions will impose position limits rules as stringent as those adopted by the CFTC.
|
•
|
The proposed rules of the Internal Revenue Service regarding the tax treatment of certain derivatives contracts which could result in a significant number of our contracts losing their 60/40 tax treatment.
|
|
2011
|
|
2010
|
|
2009
|
|||
Trading during non-U.S. hours
|
13
|
%
|
|
13
|
%
|
|
9
|
%
|
Trading through telecommunication hubs
|
7
|
%
|
|
8
|
%
|
|
7
|
%
|
ITEM 1A.
|
RISK FACTORS
|
•
|
economic, political and geopolitical market conditions;
|
•
|
natural disasters and other catastrophes;
|
•
|
broad trends in industry and finance;
|
•
|
changes in price levels, trading volumes and volatility in the derivatives markets and in underlying equity, foreign exchange, interest rate and commodity markets;
|
•
|
changes in global or regional demand or supply shifts in commodities underlying our products;
|
•
|
legislative and regulatory changes, including any direct or indirect restrictions on or increased costs associated with trading in our markets;
|
•
|
competition;
|
•
|
changes in government monetary policies;
|
•
|
availability of capital to our market participants;
|
•
|
levels of assets under management;
|
•
|
consolidation in our customer base and within our industry; and
|
•
|
inflation.
|
•
|
respond more quickly to competitive pressures, including responses based upon their corporate governance structures, which may be more flexible and efficient than our corporate governance structure;
|
•
|
develop products that are preferred by our customers;
|
•
|
develop risk transfer products that compete with our products;
|
•
|
price their products and services more competitively;
|
•
|
develop and expand their network infrastructure and service offerings more efficiently;
|
•
|
utilize better, more user-friendly and more reliable technology;
|
•
|
take greater advantage of acquisitions, alliances and other opportunities;
|
•
|
more effectively market, promote and sell their products and services;
|
•
|
better leverage existing relationships with customers and alliance partners or exploit better recognized brand names to market and sell their services; and
|
•
|
exploit regulatory disparities between traditional, regulated exchanges and alternative markets that benefit from a reduced regulatory burden and lower-cost business model.
|
•
|
provide reliable and cost-effective services to our customers;
|
•
|
develop, in a timely manner, the required functionality to support electronic trading in our key products in a manner that is competitive with the functionality supported by other electronic markets;
|
•
|
match fees of our competitors that offer only electronic trading facilities;
|
•
|
attract independent software vendors to write front-end software that will effectively access our electronic trading system and automated order routing system;
|
•
|
respond to technological developments or service offerings by competitors; and
|
•
|
generate sufficient revenue to justify the substantial capital investment we have made and will continue to make to enhance our electronic trading platform.
|
•
|
unanticipated disruptions in service to our customers;
|
•
|
slower response times;
|
•
|
delays in our customers' trade execution;
|
•
|
failed settlement of trades;
|
•
|
incomplete or inaccurate accounting, recording or processing of trades;
|
•
|
financial losses;
|
•
|
security breaches;
|
•
|
litigation or other customer claims;
|
•
|
loss of customers; and
|
•
|
regulatory sanctions.
|
•
|
restrictions on the use of trading terminals or the contracts that may be traded;
|
•
|
becoming subject to extensive regulations and oversight, tariffs and other trade barriers;
|
•
|
difficulties in staffing and managing foreign operations;
|
•
|
general economic and political conditions in the countries from which our markets are accessed, which may have an adverse effect on our volume from those countries; and
|
•
|
potentially adverse tax consequences.
|
•
|
require us to dedicate a significant portion of our cash flow from operations to payments on our debt, thereby reducing the availability of cash flow to fund capital expenditures, to pursue acquisitions or investments, to pay dividends and for general corporate purposes;
|
•
|
increase our vulnerability to general adverse economic conditions;
|
•
|
limit our flexibility in planning for, or reacting to, changes in or challenges relating to our business and industry; and
|
•
|
place us at a competitive disadvantage against any less leveraged competitors.
|
ITEM 1B.
|
UNRESOLVED STAFF COMMENTS
|
ITEM 2.
|
PROPERTIES
|
Location
|
Primary Use
|
Owned/Leased
|
Lease Expiration
|
Approximate Size
(in square feet)
(1)
|
|
|
20 South Wacker Drive, Chicago,
Illinois
|
Global headquarters and office space
|
Leased
|
2022
(2)
|
490,000
|
|
|
141 West Jackson
Chicago, Illinois
|
Chicago trading floor and office space
|
Owned
(3)
|
N/A
|
1,500,000
|
|
(4)
|
550 West Washington
Chicago, Illinois
|
Office space
|
Leased
|
2023
|
225,000
|
|
|
One North End
New York, New York
|
New York trading floor and office space
|
Mixed
(5)
|
2069
|
500,000
|
|
(6)
|
One New Change, London
|
Office space
|
Leased
|
2026
|
40,000
|
|
|
Annex Data Center
Chicagoland area
|
Business continuity
|
Leased
|
2014
|
100,000
|
|
|
Remote Data Center
Chicagoland area
|
Business continuity
|
Leased
|
2017
|
50,000
|
|
|
Data Center 3
Chicagoland area
|
Business continuity and co-location
|
Owned
|
N/A
|
430,000
|
|
|
(1)
|
Size represents the amount of space leased by us unless otherwise noted.
|
(2)
|
The initial lease expires in 2022 with two consecutive options to extend the term for seven and ten years, respectively.
|
(3)
|
In June 2011, we announced that we are pursuing a sale and partial leaseback of the north and south buildings of this location.
|
(4)
|
We occupy approximately 425,000 square feet of the 141 West Jackson complex, which includes space that is not subject to the proposed sale of the property.
|
(5)
|
The One North End property is subject to a ground lease with the Battery Park City Authority for the site of our New York offices and trading facility. In accordance with the terms of the lease, we are deemed to lease the building and its improvements from the landlord. We do not make lease payments to the landlord related to the building and we receive the financial benefit of the rental income.
|
(6)
|
We occupy approximately 350,000 square feet of the One North End Building.
|
ITEM 3.
|
LEGAL PROCEEDINGS
|
ITEM 4.
|
MINE SAFETY DISCLOSURES
|
ITEM 5.
|
MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
|
2011
|
|
High
|
|
Low
|
|
2010
|
|
High
|
|
Low
|
||||||||
First Quarter
|
|
$
|
323.43
|
|
|
$
|
279.58
|
|
|
First Quarter
|
|
$
|
353.03
|
|
|
$
|
265.75
|
|
Second Quarter
|
|
313.00
|
|
|
261.10
|
|
|
Second Quarter
|
|
347.50
|
|
|
280.78
|
|
||||
Third Quarter
|
|
298.14
|
|
|
236.50
|
|
|
Third Quarter
|
|
289.72
|
|
|
234.50
|
|
||||
Fourth Quarter
|
|
280.76
|
|
|
235.23
|
|
|
Fourth Quarter
|
|
328.00
|
|
|
255.62
|
|
Record Date
|
|
Dividend per Share
|
|
Record Date
|
|
Dividend per Share
|
||||
March 10, 2011
|
|
$
|
1.40
|
|
|
March 10, 2010
|
|
$
|
1.15
|
|
June 10, 2011
|
|
1.40
|
|
|
June 10, 2010
|
|
1.15
|
|
||
September 10, 2011
|
|
1.40
|
|
|
September 10, 2010
|
|
1.15
|
|
||
December 10, 2011
|
|
1.40
|
|
|
December 10, 2010
|
|
1.15
|
|
|
2007
|
|
2008
|
|
2009
|
|
2010
|
|
2011
|
||||||||||
CME Group Inc.
|
$
|
135.37
|
|
|
$
|
42.05
|
|
|
$
|
69.09
|
|
|
$
|
67.20
|
|
|
$
|
51.96
|
|
S&P 500
|
105.49
|
|
|
66.46
|
|
|
84.05
|
|
|
96.71
|
|
|
98.75
|
|
|||||
Peer Group
|
122.62
|
|
|
46.44
|
|
|
48.92
|
|
|
56.31
|
|
|
55.99
|
|
Period
|
|
(a) Total Number
of Shares (or Units)
Purchased
(1)
|
|
(b) Average Price
Paid Per Share (or Unit)
|
|
(c) Total Number of
Shares (or Units) Purchased as
Part of Publicly
Announced
Plans or Programs
|
|
(d) Maximum Number (or Approximate Dollar Value)
of Shares (or Units) that May Yet Be Purchased Under
the Plans or Programs
(2)
(in millions)
|
||||||
October 1 to October 31
|
|
42
|
|
|
$
|
264.79
|
|
|
—
|
|
|
$
|
529.6
|
|
November 1 to November 30
|
|
—
|
|
|
—
|
|
|
—
|
|
|
529.6
|
|
||
December 1 to December 31
|
|
1,108
|
|
|
241.56
|
|
|
—
|
|
|
529.6
|
|
||
Total
|
|
1,150
|
|
|
|
|
—
|
|
|
|
(1)
|
Shares purchased consist of an aggregate of
1,150
shares of Class A common stock surrendered to satisfy employee tax obligations upon the vesting of restricted stock.
|
(2)
|
On May 9, 2011, the board of directors authorized a share buyback program of up to $750.0 million of Class A common stock over a 12-month period.
|
ITEM 6.
|
SELECTED FINANCIAL DATA
|
|
|
Year Ended or At December 31
|
||||||||||||||||||
(in millions, except per share data)
|
|
2011
|
|
2010
|
|
2009
|
|
2008
|
|
2007
|
||||||||||
Income Statement Data:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Total revenues
|
|
$
|
3,280.6
|
|
|
$
|
3,003.7
|
|
|
$
|
2,612.8
|
|
|
$
|
2,561.0
|
|
|
$
|
1,756.1
|
|
Operating income
|
|
2,021.1
|
|
|
1,831.1
|
|
|
1,589.1
|
|
|
1,582.2
|
|
|
1,051.9
|
|
|||||
Non-operating income (expense)
|
|
(84.6
|
)
|
|
(109.2
|
)
|
|
(151.6
|
)
|
|
(334.2
|
)
|
|
43.9
|
|
|||||
Income before income taxes
|
|
1,936.5
|
|
|
1,721.9
|
|
|
1,437.5
|
|
|
1,248.0
|
|
|
1,095.8
|
|
|||||
Net income attributable to CME Group
|
|
1,812.3
|
|
|
951.4
|
|
|
825.8
|
|
|
715.5
|
|
|
658.5
|
|
|||||
Earnings per common share:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
|
$
|
27.23
|
|
|
$
|
14.35
|
|
|
$
|
12.44
|
|
|
$
|
12.18
|
|
|
$
|
15.05
|
|
Diluted
|
|
27.15
|
|
|
14.31
|
|
|
12.41
|
|
|
12.13
|
|
|
14.93
|
|
|||||
Cash dividends per share
|
|
5.60
|
|
|
4.60
|
|
|
4.60
|
|
|
9.60
|
|
|
3.44
|
|
|||||
Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Total assets
|
|
$
|
40,758.7
|
|
|
$
|
35,046.1
|
|
|
$
|
35,651.0
|
|
|
$
|
48,158.7
|
|
|
$
|
20,306.2
|
|
Short-term debt
|
|
—
|
|
|
420.5
|
|
|
299.8
|
|
|
249.9
|
|
|
164.4
|
|
|||||
Long-term debt
|
|
2,106.8
|
|
|
2,104.8
|
|
|
2,014.7
|
|
|
2,966.1
|
|
|
—
|
|
|||||
Shareholders’ equity
|
|
21,552.0
|
|
|
20,060.1
|
|
|
19,301.0
|
|
|
18,688.6
|
|
|
12,305.6
|
|
|
|
Year Ended or At December 31
|
|||||||||||||
(in thousands, except notional value)
|
|
2011
|
|
2010
|
|
2009
|
|
2008
|
|
2007
|
|||||
Average Daily Volume:
|
|
|
|
|
|
|
|
|
|
|
|||||
Product Lines:
|
|
|
|
|
|
|
|
|
|
|
|||||
Interest rate
|
|
6,030
|
|
|
5,449
|
|
|
4,260
|
|
|
6,085
|
|
|
7,093
|
|
Equity
|
|
3,238
|
|
|
2,907
|
|
|
2,916
|
|
|
3,663
|
|
|
2,744
|
|
Foreign exchange
|
|
922
|
|
|
919
|
|
|
624
|
|
|
623
|
|
|
569
|
|
Agricultural commodity
|
|
1,087
|
|
|
914
|
|
|
741
|
|
|
848
|
|
|
728
|
|
Energy
|
|
1,775
|
|
|
1,662
|
|
|
1,492
|
|
|
1,348
|
|
|
—
|
|
Metal
|
|
387
|
|
|
316
|
|
|
225
|
|
|
208
|
|
|
—
|
|
Total Average Daily Volume
|
|
13,439
|
|
|
12,167
|
|
|
10,258
|
|
|
12,775
|
|
|
11,134
|
|
Method of Trade:
|
|
|
|
|
|
|
|
|
|
|
|||||
Electronic
|
|
11,350
|
|
|
10,120
|
|
|
8,290
|
|
|
10,180
|
|
|
8,661
|
|
Open outcry
|
|
1,398
|
|
|
1,402
|
|
|
1,310
|
|
|
1,943
|
|
|
2,276
|
|
Privately negotiated
|
|
231
|
|
|
198
|
|
|
164
|
|
|
208
|
|
|
197
|
|
CME ClearPort
|
|
460
|
|
|
447
|
|
|
494
|
|
|
444
|
|
|
—
|
|
Total Average Daily Volume
|
|
13,439
|
|
|
12,167
|
|
|
10,258
|
|
|
12,775
|
|
|
11,134
|
|
Other Data:
|
|
|
|
|
|
|
|
|
|
|
|||||
Total Notional Value (in trillions)
|
|
1,068
|
|
|
994
|
|
|
813
|
|
|
1,227
|
|
|
1,134
|
|
Total Trading Volume (round turn trades)
|
|
3,386,716
|
|
|
3,078,149
|
|
|
2,584,891
|
|
|
2,978,459
|
|
|
2,249,632
|
|
Open Interest at Year End (contracts)
|
|
78,318
|
|
|
84,873
|
|
|
78,102
|
|
|
63,049
|
|
|
53,981
|
|
ITEM 7.
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
•
|
Overview
: Includes a discussion of our business structure; current economic and industry-wide trends relevant to our business; our current business strategy; and our primary sources of operating and non-operating revenues and expenses.
|
•
|
Critical Accounting Policies
: Provides an explanation of accounting policies which may have a significant impact on our financial results and the estimates, assumptions and risks associated with those policies.
|
•
|
Recent Accounting Pronouncements
: Includes an evaluation of recent accounting pronouncements and the potential impact of their future adoption on our financial results.
|
•
|
Results of Operations
: Includes a discussion of our
2011
,
2010
and
2009
financial results and any known events or trends which are likely to impact future results.
|
•
|
Liquidity and Capital Resources
: Includes a discussion of our future cash requirements, capital resources, significant planned expenditures and financing arrangements.
|
•
|
Grow our core business by launching new products, expanding our existing benchmark product lines as well as improving our customer relations in order to cross-sell our products;
|
•
|
Globalize our business by expanding and diversifying our worldwide customer base through strategic investments and relationships with other key exchanges around the world, including Asia, Latin America and other emerging markets, which allows us to accelerate our market penetration and improve product sales channels;
|
•
|
Provide superior customer service, education and sales support to our customers by restructuring our global client development and sales organization to better target cross asset sales across customer segments, drive international sales and generate new client participation across all regions throughout the world;
|
•
|
Offer a comprehensive multi-asset class clearing solution to the over-the-counter market that maximizes operational efficiency, as well as expand our over-the-counter product offerings; and
|
•
|
Establish ourselves as the leading exchange company provider of information products and index services, which would allow us to create additional cross-listing opportunities and new opportunities for index creation. It will also allow us to create opportunities for licensing across the global market as well as expanding market data dissemination services to our global network of clients and exchange partners.
|
•
|
rate structure;
|
•
|
product mix;
|
•
|
venue, and
|
•
|
the percentage of trades executed by customers who are members compared with non-member customers.
|
•
|
Communications expense includes costs for network connections to our electronic trading platform and some market data customers; telecommunications costs of our exchange; and fees paid for access to external market data. This expense may be impacted by growth in electronic trading, our capacity requirements and changes in the number of telecommunications hubs and connections which allow customers outside the United States access to our electronic trading platform directly.
|
•
|
Technology support services consist of costs related to maintenance of the hardware and software required to support our technology. Our technology support services costs are driven by system capacity, functionality and redundancy requirements.
|
•
|
Occupancy and building operations expense consists of costs related to leased and owned property including rent, maintenance, real estate taxes, utilities and other related costs. We have significant operations located in Chicago and New York City with smaller offices located throughout Europe, North and South America, the Middle East and Asia. Additionally, we have trading facilities in Chicago and New York City as well as data centers in various U.S. locations. In June 2011, we announced that we are pursuing a sale and partial leaseback of the north and south buildings of CBOT. If the sale is completed, occupancy and building operations expense will decrease.
|
•
|
Licensing and other fee agreements expense includes license fees paid as a result of trading volume in equity index products, and royalty and broker rebates on energy and metals products. This expense fluctuates with changes in equity index product volume as well as CME ClearPort volumes and fee structure changes in the agreements.
|
•
|
Other expenses include marketing and travel-related as well as general and administrative costs. Marketing, advertising and public relations expense includes media, print and other advertising costs, as well as costs associated with our product promotion. Other expenses also include litigation and customer settlements as well as impairment of operational assets and restructuring expense resulting from our mergers with CBOT Holdings and NYMEX Holdings.
|
•
|
Investment income represents income generated by short-term investment of excess cash, clearing firms' cash performance bonds and guaranty fund contributions; income and net realized gains and losses from our marketable
|
•
|
We have used derivative financial instruments for the purpose of hedging exposures to fluctuations in interest rates and foreign currency exchange rates. Any ineffective or excluded portion of our hedges is recognized in earnings immediately.
|
•
|
Interest and other borrowing costs are associated with various short-term and long-term funding facilities. We maintain a commercial paper program with various financial institutions. In early 2009, we refinanced part of the debt that was previously issued for the NYMEX Holdings merger. In conjunction with its formation, Index Services issued long-term debt in March 2010. Our debt is fixed rate debt, but debt-related costs fluctuate with the funding needs of our business as our debt levels change.
|
•
|
Income related to our guarantee of exercise right privileges (ERPs) was a result of our merger with CBOT Holdings. Under the terms of the merger agreement, eligible holders of Chicago Board Options Exchange (CBOE) ERPs could elect to sell us their ERP for $250,000 per privilege. Eligible holders that did not elect to sell their ERPs were entitled to a maximum guaranteed payment of $250,000 from us upon resolution of the lawsuit between CBOT and CBOE. This income represented the change in estimated fair value of our guarantee during the period, which was based in part on the expected outcome of the litigation. This litigation was resolved in December 2009.
|
•
|
Equity in net losses of unconsolidated subsidiaries includes income and losses from our investments in Dubai Mercantile Exchange, Green Exchange Holdings, LLC, Bursa Malaysia Derivatives Berhad and OneChicago LLC (OneChicago).
|
•
|
Other income (expense) includes income and expenses related to our securities lending program. CME's securities lending program has been suspended since 2008. NYMEX's securities lending program was terminated in June 2009.
|
•
|
Level 1—Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date. Assets and liabilities carried at level 1 fair value generally include U.S. Treasury and Government agency securities, equity securities listed in active markets, and investments in publicly traded mutual funds with quoted market prices.
|
•
|
Level 2—Inputs are either directly or indirectly observable and corroborated by market data or are based on quoted prices in markets that are not active. Assets and liabilities carried at level 2 fair value generally include municipal bonds, corporate debt and certain derivatives.
|
•
|
Level 3—Inputs are unobservable and reflect management’s best estimate of what market participants would use in pricing the asset or liability. Generally assets and liabilities at fair value utilizing level 3 inputs include certain other assets and liabilities with inputs that require management’s judgment.
|
|
|
|
|
|
|
|
|
Year-over-Year Change
|
||||||||||
(dollars in millions, except per share data)
|
|
2011
|
|
2010
|
|
2009
|
|
2011-2010
|
|
2010-2009
|
||||||||
Total revenues
|
|
$
|
3,280.6
|
|
|
$
|
3,003.7
|
|
|
$
|
2,612.8
|
|
|
9
|
%
|
|
15
|
%
|
Total expenses
|
|
1,259.5
|
|
|
1,172.6
|
|
|
1,023.7
|
|
|
7
|
|
|
15
|
|
|||
Operating margin
|
|
62
|
%
|
|
61
|
%
|
|
61
|
%
|
|
|
|
|
|||||
Non-operating income (expense)
|
|
$
|
(84.6
|
)
|
|
$
|
(109.2
|
)
|
|
$
|
(151.6
|
)
|
|
(22
|
)
|
|
(28
|
)
|
Effective tax rate
|
|
6
|
%
|
|
45
|
%
|
|
43
|
%
|
|
|
|
|
|||||
Net income attributable to CME Group
|
|
$
|
1,812.3
|
|
|
$
|
951.4
|
|
|
$
|
825.8
|
|
|
90
|
|
|
15
|
|
Diluted earnings per common share attributable to CME Group
|
|
27.15
|
|
|
14.31
|
|
|
12.41
|
|
|
90
|
|
|
15
|
|
|||
Cash flows from operating activities
|
|
1,346.3
|
|
|
1,356.4
|
|
|
1,083.1
|
|
|
(1
|
)
|
|
25
|
|
•
|
The increase in revenues from 2009 to 2011 was attributable to an increase in contract volume as well as an increase in market data and information services revenue.
|
•
|
From 2009 to 2011, higher compensation and benefits, amortization of purchased intangibles, as well as professional fees and outside services, contributed to an increase in expense. The increase in 2011 compared with 2010 was partially offset by 2010 impairment charges on the goodwill and trade name related to our CMA operations.
|
•
|
Non-operating income (expense) decreased in 2011 compared with 2010 due to lower interest expenses resulting from the repayment of the $420.5 million term loan in January 2011 and the maturity of the $300.0 million floating rate notes in August 2010. The decrease in 2010 compared with 2009 was attributable to $46.0 million of impairment of long-term investments in 2009.
|
•
|
The decrease in effective tax rate in 2011 compared with 2010 was the result of a reduction in state tax apportionment which resulted in a reduction in our income tax provision of
$646.0 million
largely due to a revaluation of our deferred tax liabilities. In addition, in the first quarter of 2011, we began marking to market our investment in BM&FBOVESPA which resulted in a
$48.8 million
reduction in valuation allowances on other unrealized capital losses previously reserved. The effective tax rate increased in 2010 compared with 2009 due to a
$51.2 million
charge to record the impact of our new combined state and local tax rate on our existing deferred tax liabilities. Our state and local tax rate increased due to revised state apportionment estimates resulting from annual state tax filings.
|
•
|
Cash flows from operations are correlated with trading volume. In 2011 when compared with 2010, the increase in cash flows from operations due to trading volumes was partially offset by an increase in other current assets and other assets resulting from an increase in restricted cash.
|
|
|
|
|
|
|
|
|
Year-over-Year Change
|
||||||||||
(dollars in millions)
|
|
2011
|
|
2010
|
|
2009
|
|
2011-2010
|
|
2010-2009
|
||||||||
Clearing and transaction fees
|
|
$
|
2,710.9
|
|
|
$
|
2,486.3
|
|
|
$
|
2,161.9
|
|
|
9
|
%
|
|
15
|
%
|
Market data and information services
|
|
427.7
|
|
|
395.1
|
|
|
331.1
|
|
|
8
|
|
|
19
|
|
|||
Access and communication fees
|
|
49.2
|
|
|
45.4
|
|
|
45.6
|
|
|
8
|
|
|
—
|
|
|||
Other
|
|
92.8
|
|
|
76.9
|
|
|
74.2
|
|
|
21
|
|
|
4
|
|
|||
Total Revenues
|
|
$
|
3,280.6
|
|
|
$
|
3,003.7
|
|
|
$
|
2,612.8
|
|
|
9
|
|
|
15
|
|
|
|
|
|
|
|
|
Year-over-Year Change
|
||||||||||
|
2011
|
|
2010
|
|
2009
|
|
2011-2010
|
|
2010-2009
|
||||||||
Total volume (in millions)
|
3,386.7
|
|
|
3,078.1
|
|
|
2,584.9
|
|
|
10
|
%
|
|
19
|
%
|
|||
Clearing and transaction fees (in millions)
|
$
|
2,710.8
|
|
|
$
|
2,486.2
|
|
|
$
|
2,161.7
|
|
|
9
|
|
|
15
|
|
Average rate per contract
|
0.800
|
|
|
0.808
|
|
|
0.836
|
|
|
(1
|
)
|
|
(3
|
)
|
|
|
Year-over-Year Change
|
||||||
(in millions)
|
|
2011-2010
|
|
2010-2009
|
||||
Increase due to change in total volume
|
|
$
|
247.0
|
|
|
$
|
398.4
|
|
Decrease due to change in average rate per contract
|
|
(22.4
|
)
|
|
(73.9
|
)
|
||
Net increase in clearing and transaction fees
|
|
$
|
224.6
|
|
|
$
|
324.5
|
|
|
|
|
|
|
|
|
|
Year-over-Year Change
|
|||||||
(amounts in thousands)
|
|
2011
|
|
2010
|
|
2009
|
|
2011-2010
|
|
2010-2009
|
|||||
Average Daily Volume by Product Line:
|
|
|
|
|
|
|
|
|
|
|
|||||
Interest rate
|
|
6,030
|
|
|
5,449
|
|
|
4,260
|
|
|
11
|
%
|
|
28
|
%
|
Equity
|
|
3,238
|
|
|
2,907
|
|
|
2,916
|
|
|
11
|
|
|
—
|
|
Foreign exchange
|
|
922
|
|
|
919
|
|
|
624
|
|
|
—
|
|
|
47
|
|
Agricultural commodity
|
|
1,087
|
|
|
914
|
|
|
741
|
|
|
19
|
|
|
23
|
|
Energy
|
|
1,775
|
|
|
1,662
|
|
|
1,492
|
|
|
7
|
|
|
11
|
|
Metal
|
|
387
|
|
|
316
|
|
|
225
|
|
|
23
|
|
|
40
|
|
Aggregate average daily volume
|
|
13,439
|
|
|
12,167
|
|
|
10,258
|
|
|
10
|
|
|
19
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Average Daily Volume by Venue:
|
|
|
|
|
|
|
|
|
|
|
|||||
Electronic
|
|
11,350
|
|
|
10,120
|
|
|
8,290
|
|
|
12
|
|
|
22
|
|
Open outcry
|
|
1,398
|
|
|
1,402
|
|
|
1,310
|
|
|
—
|
|
|
7
|
|
Privately negotiated
|
|
231
|
|
|
198
|
|
|
164
|
|
|
17
|
|
|
21
|
|
Total exchange-traded volume
|
|
12,979
|
|
|
11,720
|
|
|
9,764
|
|
|
11
|
|
|
20
|
|
Total CME ClearPort
|
|
460
|
|
|
447
|
|
|
494
|
|
|
3
|
|
|
(10
|
)
|
Aggregate average daily volume
|
|
13,439
|
|
|
12,167
|
|
|
10,258
|
|
|
10
|
|
|
19
|
|
Electronic Volume as a Percentage of Average Daily Volume
|
|
84
|
%
|
|
83
|
%
|
|
81
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Year-over-Year Change
|
||||
(amounts in thousands)
|
|
2011
|
|
2010
|
|
2009
|
|
2011-2010
|
|
2010-2009
|
||
Eurodollar futures and options:
|
|
|
|
|
|
|
|
|
|
|
||
Front 8 futures
|
|
1,717
|
|
1,646
|
|
1,482
|
|
4
|
%
|
|
11
|
%
|
Back 32 futures
|
|
510
|
|
357
|
|
238
|
|
43
|
|
|
50
|
|
Options
|
|
767
|
|
726
|
|
639
|
|
6
|
|
|
14
|
|
U.S. Treasury futures and options:
|
|
|
|
|
|
|
|
|
|
|
||
10-Year
|
|
1,454
|
|
1,380
|
|
913
|
|
5
|
|
|
51
|
|
5-Year
|
|
720
|
|
546
|
|
410
|
|
32
|
|
|
33
|
|
Treasury bond
|
|
415
|
|
388
|
|
292
|
|
7
|
|
|
33
|
|
2-Year
|
|
297
|
|
274
|
|
201
|
|
8
|
|
|
37
|
|
|
|
|
|
|
|
|
|
Year-over-Year Change
|
||||
(amounts in thousands)
|
|
2011
|
|
2010
|
|
2009
|
|
2011-2010
|
|
2010-2009
|
||
E-mini S&P 500 futures and options
|
|
2,605
|
|
2,285
|
|
2,280
|
|
14
|
%
|
|
—
|
%
|
E-mini NASDAQ 100 futures and options
|
|
301
|
|
317
|
|
311
|
|
(5
|
)
|
|
2
|
|
|
|
|
|
|
|
|
|
Year-over-Year Change
|
||||
(amounts in thousands)
|
|
2011
|
|
2010
|
|
2009
|
|
2011-2010
|
|
2010-2009
|
||
Euro
|
|
357
|
|
367
|
|
225
|
|
(3
|
)%
|
|
63
|
%
|
Australian dollar
|
|
126
|
|
105
|
|
68
|
|
20
|
|
|
55
|
|
Japanese yen
|
|
118
|
|
131
|
|
93
|
|
(10
|
)
|
|
41
|
|
British pound
|
|
118
|
|
124
|
|
100
|
|
(5
|
)
|
|
24
|
|
Canadian dollar
|
|
92
|
|
91
|
|
63
|
|
1
|
|
|
43
|
|
|
|
|
|
|
|
|
|
Year-over-Year Change
|
||||
(amounts in thousands)
|
|
2011
|
|
2010
|
|
2009
|
|
2011-2010
|
|
2010-2009
|
||
Corn
|
|
426
|
|
358
|
|
259
|
|
19
|
%
|
|
38
|
%
|
Soybean
|
|
232
|
|
186
|
|
180
|
|
25
|
|
|
3
|
|
Wheat
|
|
115
|
|
109
|
|
85
|
|
5
|
|
|
29
|
|
Soybean Oil
|
|
105
|
|
89
|
|
73
|
|
18
|
|
|
23
|
|
|
|
|
|
|
|
|
|
Year-over-Year Change
|
||||
(amounts in thousands)
|
|
2011
|
|
2010
|
|
2009
|
|
2011-2010
|
|
2010-2009
|
||
Crude oil
|
|
900
|
|
853
|
|
712
|
|
5
|
%
|
|
20
|
%
|
Natural gas
|
|
533
|
|
489
|
|
478
|
|
9
|
|
|
2
|
|
Refined products
|
|
275
|
|
244
|
|
194
|
|
13
|
|
|
26
|
|
|
|
|
|
|
|
|
|
Year-over-Year Change
|
||||
(amounts in thousands)
|
|
2011
|
|
2010
|
|
2009
|
|
2011-2010
|
|
2010-2009
|
||
Gold
|
|
238
|
|
208
|
|
159
|
|
14
|
%
|
|
31
|
%
|
Silver
|
|
87
|
|
57
|
|
36
|
|
51
|
|
|
59
|
|
|
|
|
|
|
|
|
|
Year-over-Year Change
|
||||||||||
(dollars in millions)
|
|
2011
|
|
2010
|
|
2009
|
|
2011-2010
|
|
2010-2009
|
||||||||
Compensation and benefits
|
|
$
|
475.7
|
|
|
$
|
432.1
|
|
|
$
|
351.0
|
|
|
10
|
%
|
|
23
|
%
|
Communications
|
|
42.3
|
|
|
40.6
|
|
|
47.0
|
|
|
4
|
|
|
(14
|
)
|
|||
Technology support services
|
|
52.1
|
|
|
50.5
|
|
|
46.2
|
|
|
3
|
|
|
9
|
|
|||
Professional fees and outside services
|
|
126.1
|
|
|
117.5
|
|
|
85.1
|
|
|
7
|
|
|
38
|
|
|||
Amortization of purchased intangibles
|
|
132.0
|
|
|
128.1
|
|
|
125.1
|
|
|
3
|
|
|
2
|
|
|||
Depreciation and amortization
|
|
128.5
|
|
|
129.9
|
|
|
126.3
|
|
|
(1
|
)
|
|
3
|
|
|||
Occupancy and building operations
|
|
77.5
|
|
|
74.9
|
|
|
76.3
|
|
|
3
|
|
|
(2
|
)
|
|||
Licensing and other fee agreements
|
|
84.9
|
|
|
82.6
|
|
|
89.2
|
|
|
3
|
|
|
(7
|
)
|
|||
Other
|
|
140.4
|
|
|
116.4
|
|
|
77.5
|
|
|
21
|
|
|
50
|
|
|||
Total Expenses
|
|
$
|
1,259.5
|
|
|
$
|
1,172.6
|
|
|
$
|
1,023.7
|
|
|
7
|
|
|
15
|
|
(dollars in millions)
|
|
Year-
Over-Year
Change
|
|
Change as a
Percentage of
2010 Expenses
|
|||
Salaries, benefits and employer taxes
|
|
$
|
44.2
|
|
|
4
|
%
|
MF Global-related expense
|
|
29.1
|
|
|
2
|
|
|
Stock-based compensation
|
|
10.5
|
|
|
1
|
|
|
Marketing expense
|
|
7.0
|
|
|
1
|
|
|
Professional fees related to Index Services
|
|
(10.7
|
)
|
|
(1
|
)
|
|
CMA goodwill and trade name impairment
|
|
(20.5
|
)
|
|
(2
|
)
|
|
Other expenses, net
|
|
27.3
|
|
|
2
|
|
|
Total
|
|
$
|
86.9
|
|
|
7
|
%
|
(dollars in millions)
|
|
Year-
Over-Year
Change
|
|
Change as a
Percentage of
2009 Expenses
|
|||
Salaries, benefits and employer taxes
|
|
$
|
42.7
|
|
|
4
|
%
|
Bonus expense
|
|
32.7
|
|
|
3
|
|
|
CMA goodwill and trade name impairment
|
|
20.5
|
|
|
2
|
|
|
Marketing and travel expense
|
|
15.9
|
|
|
2
|
|
|
Professional fees related to Index Services
|
|
14.7
|
|
|
2
|
|
|
Other expenses, net
|
|
22.4
|
|
|
2
|
|
|
Total
|
|
$
|
148.9
|
|
|
15
|
%
|
|
|
|
|
|
|
|
|
Year-over-Year Change
|
||||||||||
(dollars in millions)
|
|
2011
|
|
2010
|
|
2009
|
|
2011-2010
|
|
2010-2009
|
||||||||
Investment income
|
|
$
|
36.7
|
|
|
$
|
42.3
|
|
|
$
|
28.5
|
|
|
(13
|
)%
|
|
48
|
%
|
Impairment of long-term investments
|
|
—
|
|
|
(2.2
|
)
|
|
(46.0
|
)
|
|
(100
|
)
|
|
(95
|
)
|
|||
Gains (losses) on derivative investments
|
|
(0.1
|
)
|
|
(2.6
|
)
|
|
—
|
|
|
(96
|
)
|
|
n.m.
|
|
|||
Interest and other borrowing costs
|
|
(116.9
|
)
|
|
(140.3
|
)
|
|
(133.9
|
)
|
|
(17
|
)
|
|
5
|
|
|||
Guarantee of exercise rights privileges
|
|
—
|
|
|
—
|
|
|
4.3
|
|
|
—
|
|
|
(100
|
)
|
|||
Equity in net losses of unconsolidated subsidiaries
|
|
(4.3
|
)
|
|
(6.4
|
)
|
|
(6.8
|
)
|
|
(33
|
)
|
|
(6
|
)
|
|||
Other income (expense)
|
|
—
|
|
|
—
|
|
|
2.3
|
|
|
—
|
|
|
(100
|
)
|
|||
Total Non-Operating
|
|
$
|
(84.6
|
)
|
|
$
|
(109.2
|
)
|
|
$
|
(151.6
|
)
|
|
(22
|
)
|
|
(28
|
)
|
|
|
|
|
|
|
|
|
Year-over-Year Change
|
||||||||||||
(dollars in millions)
|
|
2011
|
|
2010
|
|
2009
|
|
2011-2010
|
|
2010-2009
|
||||||||||
Weighted average borrowings outstanding
|
|
$
|
2,155.8
|
|
|
$
|
2,668.1
|
|
|
$
|
2,841.8
|
|
|
$
|
(512.3
|
)
|
|
$
|
(173.7
|
)
|
Weighted average effective yield
|
|
5.18
|
%
|
|
4.96
|
%
|
|
4.23
|
%
|
|
0.22
|
%
|
|
0.73
|
%
|
|||||
Total cost of borrowing
|
|
5.47
|
|
|
5.24
|
|
|
4.76
|
|
|
0.23
|
|
|
0.48
|
|
|
2011
|
|
2010
|
|
2009
|
|
Year-over-Year Change
|
|||||||
2011-2010
|
|
2010-2009
|
||||||||||||
Year ended December 31
|
6.3
|
%
|
|
44.7
|
%
|
|
42.6
|
%
|
|
(38.4
|
)%
|
|
2.1
|
%
|
(in millions)
|
|
Operating
Leases
|
|
Purchase
Obligations
|
|
Other
Long-Term
Liabilities
|
|
Total
(1)
|
||||||||
Year
|
|
|
|
|
|
|
|
|
||||||||
2012
|
|
$
|
22.1
|
|
|
$
|
5.8
|
|
|
$
|
40.4
|
|
|
$
|
68.3
|
|
2013-2014
|
|
50.9
|
|
|
0.8
|
|
|
—
|
|
|
51.7
|
|
||||
2015-2016
|
|
45.5
|
|
|
0.7
|
|
|
—
|
|
|
46.2
|
|
||||
Thereafter
|
|
135.6
|
|
|
—
|
|
|
—
|
|
|
135.6
|
|
||||
Total
|
|
$
|
254.1
|
|
|
$
|
7.3
|
|
|
$
|
40.4
|
|
|
$
|
301.8
|
|
(1)
|
Gross unrecognized income tax liabilities, including interest and penalties, of
$53.9 million
for uncertain tax positions are not included in the table due to uncertainty about the date of their settlement.
|
|
|
|
|
|
|
|
|
Year-over-Year Change
|
||||||||||
(dollars in millions)
|
|
2011
|
|
2010
|
|
2009
|
|
2011-2010
|
|
2010-2009
|
||||||||
Net cash provided by operating activities
|
|
$
|
1,346.3
|
|
|
$
|
1,356.4
|
|
|
$
|
1,083.1
|
|
|
(1
|
)%
|
|
25
|
%
|
Net cash provided by (used in) investing activities
|
|
(153.6
|
)
|
|
(108.4
|
)
|
|
544.8
|
|
|
42
|
|
|
(120
|
)
|
|||
Net cash used in financing activities
|
|
(1,005.6
|
)
|
|
(653.4
|
)
|
|
(1,665.2
|
)
|
|
54
|
|
|
(61
|
)
|
(in millions)
|
|
Par Value
|
||
Fixed rate notes due August 2013, interest equal to 5.40%
|
|
$
|
750.0
|
|
Fixed rate notes due February 2014, interest equal to 5.75%
|
|
750.0
|
|
|
Fixed rate notes due March 2018, interest equal to 4.40%
(1)
|
|
612.5
|
|
(1)
|
In March 2010, we completed an unregistered offering of fixed rate notes due 2018. Net proceeds from the offering were used to fund a distribution to Dow Jones in conjunction with our investment in Index Services. In February 2010, we entered into a forward-starting interest rate swap agreement that modified the interest obligation associated with these notes so that the interest payable on the notes effectively became fixed at a rate of 4.46%.
|
Rating Agency
|
|
Short-Term
Debt Rating
|
|
Long-Term
Debt Rating
|
|
Outlook
|
Standard & Poor’s
|
|
A1+
|
|
AA
|
|
Negative
|
Moody’s Investors Service
|
|
P1
|
|
Aa3
|
|
Stable
|
ITEM 7A.
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
(in millions)
|
|
CME Clearing House
Available Assets
|
||
CME surplus funds
(1)
|
|
$
|
323.3
|
|
Guaranty fund contributions
(2)
|
|
2,967.8
|
|
|
Assessment powers
(3)
|
|
8,161.4
|
|
|
Minimum Total Assets Available for Default
(4)
|
|
$
|
11,452.5
|
|
(1)
|
CME surplus funds represent the amount of working capital reduced by an amount necessary to support normal operations and the amounts designated by CME for our credit default swap and interest rate swap financial safeguard packages. Our target for the CME surplus funds is $100.0 million with amounts in excess of this target generally paid as a dividend from CME to CME Group on a quarterly basis based on prior quarter-end balances.
|
(2)
|
Guaranty fund contributions of clearing firms include guaranty fund contributions required of clearing firms, but do not include any excess deposits held by our exchange at the direction of clearing firms.
|
(3)
|
In the event of a clearing firm default, if a loss continues to exist after the utilization of the assets of the defaulted firm, CME surplus funds and the non-defaulting clearing firms' guaranty fund contributions, we have the right to assess all non-defaulting clearing members as defined in the rules governing the guaranty fund.
|
(4)
|
Represents the aggregate minimum resources available to satisfy any obligations not met by a defaulting firm subsequent to the liquidation of the defaulting firm's performance bond collateral.
|
(in millions)
|
|
CME Clearing House
Available Assets
|
||
CME designated working capital for credit default swap contracts
(1)
|
|
$
|
50.0
|
|
Guaranty fund contributions
(2)
|
|
628.6
|
|
|
Minimum Total Assets Available for Default
(3)
|
|
$
|
678.6
|
|
(1)
|
CME designates working capital to satisfy a clearing firm default in the event that the defaulting clearing firm's guaranty contributions and performance bonds do not satisfy the deficit. The working capital contributed by CME would be equal to the greater of $50.0 million and 5% of the credit default swap guaranty fund, up to a maximum of $100.0 million.
|
(2)
|
Guaranty fund contributions of clearing firms for credit default swap contracts include guaranty fund contributions required of those clearing firms.
|
(3)
|
Represents the aggregate minimum resources available to satisfy any obligations not met by a defaulting firm subsequent to the liquidation of the defaulting firm's performance bond collateral. In the event of a clearing firm default, if a loss continues to exist after the utilization of the assets of the defaulted firm, CME designated working capital and the non-defaulting firms' guaranty fund contributions, we may have the right to assess all non-defaulting clearing members as defined in the rules governing the credit default swap guaranty fund.
|
(in millions)
|
|
CME Clearing House
Available Assets
|
||
CME designated working capital for interest rate swap contracts
(1)
|
|
$
|
100.0
|
|
Guaranty fund contributions
(2)
|
|
948.0
|
|
|
Minimum Total Assets Available for Default
(3)
|
|
$
|
1,048.0
|
|
(1)
|
CME designates $100.0 million of working capital to satisfy a clearing firm default in the event that the defaulting clearing firm's guaranty contributions and performance bonds do not satisfy the deficit.
|
(2)
|
Guaranty fund contributions of clearing firms for interest rate swap contracts include guaranty fund contributions required of those clearing firms.
|
(3)
|
Represents the aggregate minimum resources available to satisfy any obligations not met by a defaulting firm subsequent to the liquidation of the defaulting firm's performance bond collateral. In the event of a clearing firm default, if a loss continues to exist after the utilization of the assets of the defaulted firm, CME designated working capital and the non-defaulting firms' guaranty fund contributions, we may have the right to assess all non-defaulting clearing members as defined in the rules governing the interest rate swap guaranty fund.
|
(dollars in millions)
|
|
Cost
Basis
|
|
Fair
Value
|
|
Carrying
Value
|
|
Unrealized
Gain (Loss),
Net of Tax
|
||||||||
BM&FBOVESPA S.A.
|
|
$
|
262.9
|
|
|
$
|
527.7
|
|
|
$
|
527.7
|
|
|
$
|
168.1
|
|
Bolsa Mexicana de Valores, S.A.B. de C.V.
|
|
17.3
|
|
|
18.8
|
|
|
18.8
|
|
|
1.0
|
|
||||
IMAREX ASA
|
|
3.8
|
|
|
6.3
|
|
|
6.3
|
|
|
1.6
|
|
ITEM 8.
|
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
|
|
December 31,
|
||||||
|
2011
|
|
2010
|
||||
Assets
|
|
|
|
||||
Current Assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
1,042.3
|
|
|
$
|
855.2
|
|
Marketable securities
|
47.6
|
|
|
50.2
|
|
||
Accounts receivable, net of allowance of $1.3 and $1.6
|
289.4
|
|
|
297.5
|
|
||
Other current assets (includes $40.0 and $0 in restricted cash)
|
232.6
|
|
|
146.1
|
|
||
Cash performance bonds and guaranty fund contributions
|
9,333.9
|
|
|
4,038.5
|
|
||
Total current assets
|
10,945.8
|
|
|
5,387.5
|
|
||
Property, net of accumulated depreciation and amortization
|
821.9
|
|
|
786.8
|
|
||
Intangible assets—trading products
|
17,040.5
|
|
|
17,040.5
|
|
||
Intangible assets—other, net
|
3,312.8
|
|
|
3,453.3
|
|
||
Goodwill
|
7,984.0
|
|
|
7,983.6
|
|
||
Other assets (includes $20.5 and $0 in restricted cash)
|
653.7
|
|
|
394.4
|
|
||
Total Assets
|
$
|
40,758.7
|
|
|
$
|
35,046.1
|
|
|
|
|
|
||||
Liabilities and Shareholders’ Equity
|
|
|
|
||||
Current Liabilities:
|
|
|
|
||||
Accounts payable
|
$
|
31.1
|
|
|
$
|
51.8
|
|
Short-term debt
|
—
|
|
|
420.5
|
|
||
Other current liabilities
|
250.2
|
|
|
270.4
|
|
||
Cash performance bonds and guaranty fund contributions
|
9,333.9
|
|
|
4,038.5
|
|
||
Total current liabilities
|
9,615.2
|
|
|
4,781.2
|
|
||
Long-term debt
|
2,106.8
|
|
|
2,104.8
|
|
||
Deferred tax liabilities, net
|
7,226.8
|
|
|
7,840.4
|
|
||
Other liabilities
|
187.6
|
|
|
191.5
|
|
||
Total Liabilities
|
19,136.4
|
|
|
14,917.9
|
|
||
|
|
|
|
||||
Redeemable non-controlling interest
|
70.3
|
|
|
68.1
|
|
||
|
|
|
|
||||
Shareholders’ Equity:
|
|
|
|
||||
Preferred stock, $0.01 par value, 9,860 shares authorized, none issued or outstanding
|
—
|
|
|
—
|
|
||
Series A junior participating preferred stock, $0.01 par value, 140 shares authorized, none issued or outstanding
|
—
|
|
|
—
|
|
||
Class A common stock, $0.01 par value, 1,000,000 shares authorized, 66,128 and 66,847 shares issued and outstanding as of December 31, 2011 and 2010, respectively
|
0.7
|
|
|
0.7
|
|
||
Class B common stock, $0.01 par value, 3 shares authorized, issued and outstanding
|
—
|
|
|
—
|
|
||
Additional paid-in capital
|
17,115.1
|
|
|
17,277.7
|
|
||
Retained earnings
|
4,324.6
|
|
|
2,885.8
|
|
||
Accumulated other comprehensive income (loss)
|
111.6
|
|
|
(104.1
|
)
|
||
Total Shareholders’ Equity
|
21,552.0
|
|
|
20,060.1
|
|
||
Total Liabilities and Shareholders’ Equity
|
$
|
40,758.7
|
|
|
$
|
35,046.1
|
|
|
Year Ended December 31,
|
||||||||||
|
2011
|
|
2010
|
|
2009
|
||||||
Revenues
|
|
|
|
|
|
||||||
Clearing and transaction fees
|
$
|
2,710.9
|
|
|
$
|
2,486.3
|
|
|
$
|
2,161.9
|
|
Market data and information services
|
427.7
|
|
|
395.1
|
|
|
331.1
|
|
|||
Access and communication fees
|
49.2
|
|
|
45.4
|
|
|
45.6
|
|
|||
Other
|
92.8
|
|
|
76.9
|
|
|
74.2
|
|
|||
Total Revenues
|
3,280.6
|
|
|
3,003.7
|
|
|
2,612.8
|
|
|||
Expenses
|
|
|
|
|
|
||||||
Compensation and benefits
|
475.7
|
|
|
432.1
|
|
|
351.0
|
|
|||
Communications
|
42.3
|
|
|
40.6
|
|
|
47.0
|
|
|||
Technology support services
|
52.1
|
|
|
50.5
|
|
|
46.2
|
|
|||
Professional fees and outside services
|
126.1
|
|
|
117.5
|
|
|
85.1
|
|
|||
Amortization of purchased intangibles
|
132.0
|
|
|
128.1
|
|
|
125.1
|
|
|||
Depreciation and amortization
|
128.5
|
|
|
129.9
|
|
|
126.3
|
|
|||
Occupancy and building operations
|
77.5
|
|
|
74.9
|
|
|
76.3
|
|
|||
Licensing and other fee agreements
|
84.9
|
|
|
82.6
|
|
|
89.2
|
|
|||
Other
|
140.4
|
|
|
116.4
|
|
|
77.5
|
|
|||
Total Expenses
|
1,259.5
|
|
|
1,172.6
|
|
|
1,023.7
|
|
|||
Operating Income
|
2,021.1
|
|
|
1,831.1
|
|
|
1,589.1
|
|
|||
|
|
|
|
|
|
||||||
Non-Operating Income (Expense)
|
|
|
|
|
|
||||||
Investment income
|
36.7
|
|
|
42.3
|
|
|
28.5
|
|
|||
Impairment of long-term investments
|
—
|
|
|
(2.2
|
)
|
|
(46.0
|
)
|
|||
Gains (losses) on derivative investments
|
(0.1
|
)
|
|
(2.6
|
)
|
|
—
|
|
|||
Interest and other borrowing costs
|
(116.9
|
)
|
|
(140.3
|
)
|
|
(133.9
|
)
|
|||
Guarantee of exercise right privileges
|
—
|
|
|
—
|
|
|
4.3
|
|
|||
Equity in net losses of unconsolidated subsidiaries
|
(4.3
|
)
|
|
(6.4
|
)
|
|
(6.8
|
)
|
|||
Other income (expense)
|
—
|
|
|
—
|
|
|
2.3
|
|
|||
Total Non-Operating
|
(84.6
|
)
|
|
(109.2
|
)
|
|
(151.6
|
)
|
|||
Income before Income Taxes
|
1,936.5
|
|
|
1,721.9
|
|
|
1,437.5
|
|
|||
Income tax provision
|
122.1
|
|
|
769.8
|
|
|
611.7
|
|
|||
Net Income
|
1,814.4
|
|
|
952.1
|
|
|
825.8
|
|
|||
Less: net income attributable to redeemable non-controlling interest
|
2.1
|
|
|
0.7
|
|
|
—
|
|
|||
Net Income Attributable to CME Group
|
$
|
1,812.3
|
|
|
$
|
951.4
|
|
|
$
|
825.8
|
|
Earnings per Common Share Attributable to CME Group:
|
|
|
|
|
|
||||||
Basic
|
$
|
27.23
|
|
|
$
|
14.35
|
|
|
$
|
12.44
|
|
Diluted
|
27.15
|
|
|
14.31
|
|
|
12.41
|
|
|||
Weighted Average Number of Common Shares:
|
|
|
|
|
|
||||||
Basic
|
66,547
|
|
|
66,299
|
|
|
66,366
|
|
|||
Diluted
|
66,762
|
|
|
66,495
|
|
|
66,548
|
|
|
Class A
Common
Stock
(Shares)
|
|
Class B
Common
Stock
(Shares)
|
|
Common
Stock and
Additional
Paid-in
Capital
|
|
Retained
Earnings
|
|
Accumulated
Other
Comprehensive
Income (Loss)
|
|
Total
Shareholders’
Equity
|
||||||||
Balance at December 31, 2008
|
66,417
|
|
3
|
|
$
|
17,129.2
|
|
|
$
|
1,719.7
|
|
|
$
|
(160.3
|
)
|
|
$
|
18,688.6
|
|
Comprehensive income attributable to CME Group:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Net income attributable to CME Group
|
|
|
|
|
|
|
825.8
|
|
|
|
|
825.8
|
|
||||||
Change in net unrealized loss on securities, net of tax of $16.5
|
|
|
|
|
|
|
|
|
25.4
|
|
|
25.4
|
|
||||||
Change in net actuarial loss on defined benefit plans, net of tax of $0.9
|
|
|
|
|
|
|
|
|
(1.4
|
)
|
|
(1.4
|
)
|
||||||
Net change in derivative instruments, net of tax of $4.7
|
|
|
|
|
|
|
|
|
7.5
|
|
|
7.5
|
|
||||||
Change in foreign currency translation adjustment, net of tax of $1.7
|
|
|
|
|
|
|
|
|
2.6
|
|
|
2.6
|
|
||||||
Total comprehensive income attributable to CME Group
|
|
|
|
|
|
|
|
|
|
|
859.9
|
|
|||||||
Dividends on common stock of $4.60 per share
|
|
|
|
|
|
|
(305.6
|
)
|
|
|
|
(305.6
|
)
|
||||||
Class A common stock issued in exchange for investment in Bursa Malaysia Derivatives Berhad
|
76
|
|
|
|
25.1
|
|
|
|
|
|
|
25.1
|
|
||||||
Repurchase of Class A common stock
|
(139)
|
|
|
|
(27.0
|
)
|
|
|
|
|
|
(27.0
|
)
|
||||||
Exercise of stock options
|
125
|
|
|
|
22.0
|
|
|
|
|
|
|
22.0
|
|
||||||
Excess tax benefits from option exercises and restricted stock vesting
|
|
|
|
|
2.3
|
|
|
|
|
|
|
2.3
|
|
||||||
Vesting of issued restricted Class A common stock
|
16
|
|
|
|
(1.6
|
)
|
|
|
|
|
|
(1.6
|
)
|
||||||
Shares issued to Board of Directors
|
12
|
|
|
|
2.4
|
|
|
|
|
|
|
2.4
|
|
||||||
Shares issued under Employee Stock Purchase Plan
|
4
|
|
|
|
1.5
|
|
|
|
|
|
|
1.5
|
|
||||||
Stock-based compensation
|
|
|
|
|
33.4
|
|
|
|
|
|
|
33.4
|
|
||||||
Balance at December 31, 2009
|
66,511
|
|
3
|
|
$
|
17,187.3
|
|
|
$
|
2,239.9
|
|
|
$
|
(126.2
|
)
|
|
$
|
19,301.0
|
|
|
Class A
Common
Stock
(Shares)
|
|
Class B
Common
Stock
(Shares)
|
|
Common
Stock and
Additional
Paid-in
Capital
|
|
Retained
Earnings
|
|
Accumulated
Other
Comprehensive
Income (Loss)
|
|
Total
Shareholders’
Equity
|
||||||||
Balance at December 31, 2009
|
66,511
|
|
3
|
|
$
|
17,187.3
|
|
|
$
|
2,239.9
|
|
|
$
|
(126.2
|
)
|
|
$
|
19,301.0
|
|
Comprehensive income attributable to CME Group:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Net income attributable to CME Group
|
|
|
|
|
|
|
951.4
|
|
|
|
|
951.4
|
|
||||||
Change in net unrealized gain on securities, net of tax of $3.6
|
|
|
|
|
|
|
|
|
5.3
|
|
|
5.3
|
|
||||||
Change in net actuarial loss on defined benefit plans, net of tax of $3.8
|
|
|
|
|
|
|
|
|
5.8
|
|
|
5.8
|
|
||||||
Net change in derivative instruments, net of tax of $7.4
|
|
|
|
|
|
|
|
|
11.5
|
|
|
11.5
|
|
||||||
Change in foreign currency translation adjustment, net of tax of $0.4
|
|
|
|
|
|
|
|
|
(0.5
|
)
|
|
(0.5
|
)
|
||||||
Total comprehensive income attributable to CME Group
|
|
|
|
|
|
|
|
|
|
|
973.5
|
|
|||||||
Dividends on common stock of $4.60 per share
|
|
|
|
|
|
|
(305.5
|
)
|
|
|
|
(305.5
|
)
|
||||||
Class A common stock issued to BM&FBOVESPA S.A.
|
2,206
|
|
|
|
607.1
|
|
|
|
|
|
|
607.1
|
|
||||||
Repurchase of Class A common stock
|
(2,007)
|
|
|
|
(575.3
|
)
|
|
|
|
|
|
(575.3
|
)
|
||||||
Exercise of stock options
|
90
|
|
|
|
12.6
|
|
|
|
|
|
|
12.6
|
|
||||||
Excess tax benefits from option exercises and restricted stock vesting
|
|
|
|
|
5.8
|
|
|
|
|
|
|
5.8
|
|
||||||
Vesting of issued restricted Class A common stock
|
35
|
|
|
|
(3.8
|
)
|
|
|
|
|
|
(3.8
|
)
|
||||||
Shares issued to Board of Directors
|
8
|
|
|
|
2.4
|
|
|
|
|
|
|
2.4
|
|
||||||
Shares issued under Employee Stock Purchase Plan
|
4
|
|
|
|
1.4
|
|
|
|
|
|
|
1.4
|
|
||||||
Stock-based compensation
|
|
|
|
|
40.9
|
|
|
|
|
|
|
40.9
|
|
||||||
Balance at December 31, 2010
|
66,847
|
|
3
|
|
$
|
17,278.4
|
|
|
$
|
2,885.8
|
|
|
$
|
(104.1
|
)
|
|
$
|
20,060.1
|
|
|
Class A
Common
Stock
(Shares)
|
|
Class B
Common
Stock
(Shares)
|
|
Common
Stock and
Additional
Paid-in
Capital
|
|
Retained
Earnings
|
|
Accumulated
Other
Comprehensive
Income (Loss)
|
|
Total
Shareholders’
Equity
|
||||||||
Balance at December 31, 2010
|
66,847
|
|
3
|
|
$
|
17,278.4
|
|
|
$
|
2,885.8
|
|
|
$
|
(104.1
|
)
|
|
$
|
20,060.1
|
|
Comprehensive income attributable to CME Group:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Net income attributable to CME Group
|
|
|
|
|
|
|
1,812.3
|
|
|
|
|
1,812.3
|
|
||||||
Change in net unrealized gain on securities, net of tax of $23.7
|
|
|
|
|
|
|
|
|
142.7
|
|
|
142.7
|
|
||||||
Change in net actuarial loss on defined benefit plans, net of tax of $6.5
|
|
|
|
|
|
|
|
|
(10.9
|
)
|
|
(10.9
|
)
|
||||||
Net change in derivative instruments, net of tax of $0.3
|
|
|
|
|
|
|
|
|
0.6
|
|
|
0.6
|
|
||||||
Change in foreign currency translation adjustment, net of tax of $13.3
|
|
|
|
|
|
|
|
|
83.3
|
|
|
83.3
|
|
||||||
Total comprehensive income attributable to CME Group
|
|
|
|
|
|
|
|
|
|
|
2,028.0
|
|
|||||||
Dividends on common stock of $5.60 per share
|
|
|
|
|
|
|
(373.5
|
)
|
|
|
|
(373.5
|
)
|
||||||
Repurchase of Class A common stock
|
(810)
|
|
|
|
(220.4
|
)
|
|
|
|
|
|
(220.4
|
)
|
||||||
Exercise of stock options
|
34
|
|
|
|
5.8
|
|
|
|
|
|
|
5.8
|
|
||||||
Excess tax benefits from option exercises and restricted stock vesting
|
|
|
|
|
0.6
|
|
|
|
|
|
|
0.6
|
|
||||||
Vesting of issued restricted Class A common stock
|
43
|
|
|
|
(3.8
|
)
|
|
|
|
|
|
(3.8
|
)
|
||||||
Shares issued to Board of Directors
|
8
|
|
|
|
2.3
|
|
|
|
|
|
|
2.3
|
|
||||||
Shares issued under Employee Stock Purchase Plan
|
6
|
|
|
|
1.6
|
|
|
|
|
|
|
1.6
|
|
||||||
Stock-based compensation
|
|
|
|
|
51.3
|
|
|
|
|
|
|
51.3
|
|
||||||
Balance at December 31, 2011
|
66,128
|
|
3
|
|
$
|
17,115.8
|
|
|
$
|
4,324.6
|
|
|
$
|
111.6
|
|
|
$
|
21,552.0
|
|
|
Year Ended December 31,
|
||||||||||
|
2011
|
|
2010
|
|
2009
|
||||||
Cash Flows from Operating Activities
|
|
|
|
|
|
||||||
Net income
|
$
|
1,814.4
|
|
|
$
|
952.1
|
|
|
$
|
825.8
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
||||||
Stock-based compensation
|
51.3
|
|
|
40.9
|
|
|
33.4
|
|
|||
Amortization of purchased intangibles
|
132.0
|
|
|
128.1
|
|
|
125.1
|
|
|||
Depreciation and amortization
|
128.5
|
|
|
129.9
|
|
|
126.3
|
|
|||
Net loss on derivative investments
|
—
|
|
|
8.6
|
|
|
—
|
|
|||
Impairment of goodwill and intangible assets
|
—
|
|
|
20.5
|
|
|
—
|
|
|||
Impairment of long-term investments
|
—
|
|
|
2.2
|
|
|
46.0
|
|
|||
MF Global accounts receivable write-off
|
21.7
|
|
|
—
|
|
|
—
|
|
|||
Amortization of debt financing costs and discount accretion
|
4.9
|
|
|
4.9
|
|
|
12.7
|
|
|||
Gain on sale of Index Services assets
|
(9.8
|
)
|
|
—
|
|
|
—
|
|
|||
Guarantee of exercise right privileges
|
—
|
|
|
—
|
|
|
(4.3
|
)
|
|||
Equity in net losses of unconsolidated subsidiaries
|
4.3
|
|
|
6.4
|
|
|
6.8
|
|
|||
Deferred income taxes
|
(658.7
|
)
|
|
22.3
|
|
|
(56.9
|
)
|
|||
Change in assets and liabilities:
|
|
|
|
|
|
||||||
Accounts receivable
|
(13.2
|
)
|
|
(28.7
|
)
|
|
(14.4
|
)
|
|||
Other current assets
|
(69.4
|
)
|
|
(29.9
|
)
|
|
(7.4
|
)
|
|||
Other assets
|
(27.1
|
)
|
|
(6.1
|
)
|
|
(6.9
|
)
|
|||
Accounts payable
|
(21.0
|
)
|
|
6.1
|
|
|
(24.3
|
)
|
|||
Income taxes payable
|
(18.0
|
)
|
|
12.4
|
|
|
13.8
|
|
|||
Other current liabilities
|
(6.5
|
)
|
|
79.6
|
|
|
(23.3
|
)
|
|||
Other liabilities
|
13.2
|
|
|
5.3
|
|
|
30.7
|
|
|||
Other
|
(0.3
|
)
|
|
1.8
|
|
|
—
|
|
|||
Net Cash Provided by Operating Activities
|
1,346.3
|
|
|
1,356.4
|
|
|
1,083.1
|
|
|||
|
|
|
|
|
|
||||||
Cash Flows from Investing Activities
|
|
|
|
|
|
||||||
Proceeds from maturities of available-for-sale marketable securities
|
11.3
|
|
|
11.9
|
|
|
439.8
|
|
|||
Purchases of available-for-sale marketable securities
|
(10.2
|
)
|
|
(10.2
|
)
|
|
(159.9
|
)
|
|||
Net change in NYMEX securities lending program investments
|
—
|
|
|
—
|
|
|
425.9
|
|
|||
Purchases of property, net
|
(172.2
|
)
|
|
(160.0
|
)
|
|
(157.9
|
)
|
|||
Consideration paid in business combinations, net of cash acquired
|
—
|
|
|
(19.6
|
)
|
|
—
|
|
|||
Proceeds from sale of Index Services assets
|
18.0
|
|
|
—
|
|
|
—
|
|
|||
Proceeds from sale of long-term investment
|
—
|
|
|
47.2
|
|
|
—
|
|
|||
Proceeds from Chicago Board Options Exchange exercise right privileges
|
—
|
|
|
39.7
|
|
|
—
|
|
|||
Purchase of Bolsa Mexicana de Valores, S.A.B. de C.V. shares
|
—
|
|
|
(17.4
|
)
|
|
—
|
|
|||
Capital contributions to FXMarketSpace Limited
|
—
|
|
|
—
|
|
|
(3.1
|
)
|
|||
Other
|
(0.5
|
)
|
|
—
|
|
|
—
|
|
|||
Net Cash Provided by (Used in) Investing Activities
|
(153.6
|
)
|
|
(108.4
|
)
|
|
544.8
|
|
|
Year Ended December 31,
|
||||||||||
|
2011
|
|
2010
|
|
2009
|
||||||
Cash Flows from Financing Activities
|
|
|
|
|
|
||||||
Proceeds (repayments) of commercial paper, net
|
—
|
|
|
(99.9
|
)
|
|
(1,393.6
|
)
|
|||
Proceeds from other borrowings, net of issuance costs
|
—
|
|
|
608.0
|
|
|
743.5
|
|
|||
Repayment of other borrowings
|
(420.5
|
)
|
|
(300.0
|
)
|
|
(250.0
|
)
|
|||
Net change in NYMEX securities lending program liabilities
|
—
|
|
|
—
|
|
|
(456.8
|
)
|
|||
Cash dividends
|
(372.8
|
)
|
|
(305.3
|
)
|
|
(305.6
|
)
|
|||
Class A common stock issued to BM&FBOVESPA SA
|
—
|
|
|
607.1
|
|
|
—
|
|
|||
Repurchase of Class A common stock, including costs
|
(220.4
|
)
|
|
(575.3
|
)
|
|
(27.0
|
)
|
|||
Proceeds from exercise of stock options
|
5.8
|
|
|
12.6
|
|
|
20.4
|
|
|||
Distribution paid to non-controlling interest
|
—
|
|
|
(607.5
|
)
|
|
—
|
|
|||
Excess tax benefits related to employee option exercises and restricted stock vesting
|
0.6
|
|
|
5.8
|
|
|
2.5
|
|
|||
Other
|
1.7
|
|
|
1.1
|
|
|
1.4
|
|
|||
Net Cash Used in Financing Activities
|
(1,005.6
|
)
|
|
(653.4
|
)
|
|
(1,665.2
|
)
|
|||
|
|
|
|
|
|
||||||
Net change in cash and cash equivalents
|
187.1
|
|
|
594.6
|
|
|
(37.3
|
)
|
|||
Cash and cash equivalents, beginning of period
|
855.2
|
|
|
260.6
|
|
|
297.9
|
|
|||
Cash and Cash Equivalents, End of Period
|
$
|
1,042.3
|
|
|
$
|
855.2
|
|
|
$
|
260.6
|
|
|
|
|
|
|
|
||||||
Supplemental Disclosure of Cash Flow Information
|
|
|
|
|
|
||||||
Income taxes paid
|
$
|
816.1
|
|
|
$
|
765.9
|
|
|
$
|
629.7
|
|
Interest paid
|
111.9
|
|
|
104.9
|
|
|
90.8
|
|
|||
Non-cash investing activities:
|
|
|
|
|
|
||||||
Change in net unrealized securities gains (losses)
|
166.4
|
|
|
8.9
|
|
|
41.9
|
|
|||
Change in net unrealized derivatives gains (losses)
|
0.9
|
|
|
10.4
|
|
|
12.2
|
|
•
|
Level 1-Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date. Assets and liabilities carried at level 1 fair value generally include U.S. Treasury and Government agency securities, equity securities listed in active markets, and investments in publicly traded mutual funds with quoted market prices.
|
•
|
Level 2-Inputs are either directly or indirectly observable and corroborated by market data or are based on quoted prices in markets that are not active. Assets and liabilities carried at level 2 fair value generally include municipal bonds, corporate debt and certain derivatives.
|
•
|
Level 3-Inputs are unobservable and reflect management's best estimate of what market participants would use in pricing the asset or liability. Generally, assets and liabilities at fair value utilizing level 3 inputs include certain other assets and liabilities with inputs that require management's judgment. Assets and liabilities at fair value utilizing level 3 inputs can also include certain assets and liabilities that are tested for impairment and measured at fair value on a non-recurring basis.
|
|
|
2011
|
|
2010
|
||||||||||||
(in millions)
|
|
Amortized
Cost
|
|
Fair
Value
|
|
Amortized
Cost
|
|
Fair
Value
|
||||||||
U.S. Government agency
|
|
$
|
4.9
|
|
|
$
|
5.3
|
|
|
$
|
9.7
|
|
|
$
|
9.8
|
|
U.S. Treasury
|
|
5.1
|
|
|
5.1
|
|
|
5.1
|
|
|
5.1
|
|
||||
Municipal bonds
|
|
4.1
|
|
|
4.5
|
|
|
4.3
|
|
|
4.3
|
|
||||
Asset-back securities
|
|
1.1
|
|
|
0.9
|
|
|
2.2
|
|
|
2.1
|
|
||||
Corporate bonds
|
|
—
|
|
|
—
|
|
|
0.1
|
|
|
0.1
|
|
||||
Total
|
|
$
|
15.2
|
|
|
$
|
15.8
|
|
|
$
|
21.4
|
|
|
$
|
21.4
|
|
(in millions)
|
|
Amortized
Cost
|
|
Fair
Value
|
||||
Maturity of one year or less
|
|
$
|
5.2
|
|
|
$
|
5.2
|
|
Maturity between one and five years
|
|
3.9
|
|
|
4.3
|
|
||
Maturity between five and ten years
|
|
2.3
|
|
|
2.6
|
|
||
Maturity greater than ten years
|
|
3.8
|
|
|
3.7
|
|
||
Total
|
|
$
|
15.2
|
|
|
$
|
15.8
|
|
|
|
2011
|
|
2010
|
||||||||||||
(in millions)
|
|
Cash
|
|
Non-Cash
Deposits
and
IEF Funds
|
|
Cash
|
|
Non-Cash
Deposits
and
IEF Funds
|
||||||||
Performance bonds
|
|
$
|
8,103.4
|
|
|
$
|
80,250.7
|
|
|
$
|
3,717.0
|
|
|
$
|
82,867.7
|
|
Guaranty fund contributions
|
|
1,156.3
|
|
|
3,869.8
|
|
|
231.8
|
|
|
2,828.3
|
|
||||
Cross-margin arrangements
|
|
60.0
|
|
|
202.9
|
|
|
79.7
|
|
|
196.8
|
|
||||
Performance collateral for delivery
|
|
14.2
|
|
|
12.0
|
|
|
10.0
|
|
|
2.1
|
|
||||
Total
|
|
$
|
9,333.9
|
|
|
$
|
84,335.4
|
|
|
$
|
4,038.5
|
|
|
$
|
85,894.9
|
|
(in millions)
|
|
2011
|
|
2010
|
||||
Performance bonds
|
|
$
|
4,214.8
|
|
|
$
|
4,071.8
|
|
Performance collateral for delivery
|
|
1,449.3
|
|
|
1,416.6
|
|
||
Total Letters of Credit
|
|
$
|
5,664.1
|
|
|
$
|
5,488.4
|
|
(in millions)
|
|
2011
|
|
2010
|
|
Estimated Useful Life
|
||||
Land and land improvements
|
|
$
|
65.6
|
|
|
$
|
65.2
|
|
|
10 - 20 years
(1)
|
Building and building improvements
|
|
531.7
|
|
|
454.9
|
|
|
3 - 39 years
|
||
Leasehold improvements
|
|
214.6
|
|
|
201.9
|
|
|
3 - 24 years
|
||
Furniture, fixtures and equipment
|
|
328.3
|
|
|
330.3
|
|
|
2 - 7 years
|
||
Software and software development costs
|
|
258.0
|
|
|
247.4
|
|
|
2 - 4 years
|
||
Total property
|
|
1,398.2
|
|
|
1,299.7
|
|
|
|
||
Less accumulated depreciation and amortization
|
|
(576.3
|
)
|
|
(512.9
|
)
|
|
|
||
Property, net
|
|
$
|
821.9
|
|
|
$
|
786.8
|
|
|
|
|
|
2011
|
|
2010
|
||||||||||||||||||||
(in millions)
|
|
Assigned Value
|
|
Accumulated
Amortization
|
|
Net Book
Value
|
|
Assigned Value
|
|
Accumulated
Amortization
|
|
Net Book
Value
|
||||||||||||
Amortizable Intangible Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Clearing firm, market data and other customer relationships
(1)
|
|
$
|
3,071.9
|
|
|
$
|
(400.4
|
)
|
|
$
|
2,671.5
|
|
|
$
|
3,081.0
|
|
|
$
|
(292.3
|
)
|
|
$
|
2,788.7
|
|
Lease-related intangibles
|
|
83.2
|
|
|
(45.4
|
)
|
|
37.8
|
|
|
83.2
|
|
|
(33.5
|
)
|
|
49.7
|
|
||||||
Technology-related intellectual property
|
|
56.2
|
|
|
(28.4
|
)
|
|
27.8
|
|
|
51.3
|
|
|
(17.8
|
)
|
|
33.5
|
|
||||||
Other
(2)
|
|
11.6
|
|
|
(10.6
|
)
|
|
1.0
|
|
|
15.1
|
|
|
(11.8
|
)
|
|
3.3
|
|
||||||
|
|
3,222.9
|
|
|
(484.8
|
)
|
|
2,738.1
|
|
|
3,230.6
|
|
|
(355.4
|
)
|
|
2,875.2
|
|
||||||
Foreign currency translation adjustments
|
|
(8.8
|
)
|
|
5.9
|
|
|
(2.9
|
)
|
|
(8.7
|
)
|
|
4.3
|
|
|
(4.4
|
)
|
||||||
Total amortizable intangible assets
|
|
$
|
3,214.1
|
|
|
$
|
(478.9
|
)
|
|
2,735.2
|
|
|
$
|
3,221.9
|
|
|
$
|
(351.1
|
)
|
|
2,870.8
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Indefinite-Lived Intangible Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Trade names
|
|
|
|
|
|
578.0
|
|
|
|
|
|
|
582.9
|
|
||||||||||
Foreign currency translation adjustments
|
|
|
|
|
|
(0.4
|
)
|
|
|
|
|
|
(0.4
|
)
|
||||||||||
Total intangible assets—other, net
|
|
|
|
|
|
$
|
3,312.8
|
|
|
|
|
|
|
$
|
3,453.3
|
|
||||||||
Trading products
(3)
|
|
|
|
|
|
$
|
17,040.5
|
|
|
|
|
|
|
$
|
17,040.5
|
|
(1)
|
In the second quarter of 2011, the company sold its rights in certain Index Services customer relationships for
$18.0 million
. The net book value of these assets at the time of the sale was
$8.2 million
.
|
(2)
|
At
December 31, 2011
and
2010
, other amortizable intangible assets consisted of service and market maker agreements and a definite-lived trade name.
|
(3)
|
Trading products represent futures and options products acquired in our business combinations with CBOT Holdings and NYMEX Holdings. Clearing and transaction fees revenues are generated through the trading of these products. These trading products, most of which have traded for decades, require authorization from the Commodity and Futures Trading Commission (CFTC). Product authorizations from the CFTC have no term limits.
|
|
|
Clearing firm, market data and other customer relationships
|
5 - 30 years
|
Lease-related intangible assets
|
4 - 13 years
|
Technology-related intellectual property
|
2.5 - 15 years
|
Other
|
3 - 8 years
|
(in millions)
|
|
||
2012
|
$
|
126.3
|
|
2013
|
120.2
|
|
|
2014
|
118.5
|
|
|
2015
|
114.6
|
|
|
2016
|
109.3
|
|
|
Thereafter
|
2,146.3
|
|
(in millions)
|
|
Balance at December 31, 2010
|
|
Business
Combinations
|
|
Impairment
Adjustment
|
|
Other
Activity
(4)
|
|
Balance at December 31, 2011
|
||||||||||
CBOT Holdings
|
|
$
|
5,035.7
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
5,035.7
|
|
NYMEX Holdings
|
|
2,462.3
|
|
|
—
|
|
|
—
|
|
|
(0.1
|
)
|
|
2,462.2
|
|
|||||
Index Services
|
|
435.6
|
|
|
—
|
|
|
—
|
|
|
(1.1
|
)
|
|
434.5
|
|
|||||
Other
|
|
50.0
|
|
|
—
|
|
|
—
|
|
|
1.6
|
|
|
51.6
|
|
|||||
Total Goodwill
|
|
$
|
7,983.6
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
0.4
|
|
|
$
|
7,984.0
|
|
(in millions)
|
|
Balance at December 31, 2009
|
|
Business
Combinations
|
|
Impairment
Adjustment
|
|
Other
Activity
(4)
|
|
Balance at December 31, 2010
|
||||||||||
CBOT Holdings
|
|
$
|
5,035.7
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
5,035.7
|
|
NYMEX Holdings
|
|
2,463.1
|
|
|
—
|
|
|
—
|
|
|
(0.8
|
)
|
|
2,462.3
|
|
|||||
Index Services
|
|
—
|
|
|
435.6
|
|
|
—
|
|
|
—
|
|
|
435.6
|
|
|||||
Other
|
|
50.4
|
|
|
21.1
|
|
|
(19.8
|
)
|
|
(1.7
|
)
|
|
50.0
|
|
|||||
Total Goodwill
|
|
$
|
7,549.2
|
|
|
$
|
456.7
|
|
|
$
|
(19.8
|
)
|
|
$
|
(2.5
|
)
|
|
$
|
7,983.6
|
|
(4)
|
Other activity includes adjustments to restructuring costs and tax contingencies, the recognition of excess tax benefits upon exercise of stock options and foreign currency translation adjustments.
|
(in millions)
|
|
Minimum
Rental
Payments
|
||
2012
|
|
$
|
28.6
|
|
2013
|
|
21.3
|
|
|
2014
|
|
13.9
|
|
|
2015
|
|
10.3
|
|
|
2016
|
|
6.6
|
|
(in millions)
|
|
2011
|
|
2010
|
||||
Term loan due 2011, interest equal to 3-month LIBOR plus 1.00%, reset quarterly
(1)
|
|
$
|
—
|
|
|
$
|
420.5
|
|
Total short-term debt
|
|
$
|
—
|
|
|
$
|
420.5
|
|
(1)
|
In September 2008, the company entered into an interest rate swap agreement that modified the variable interest obligation associated with this loan so that the interest payable effectively became fixed at a rate of
4.72%
beginning with the interest accrued after October 22, 2008. This interest rate swap agreement was terminated in January 2011 when the term loan was repaid.
|
(in millions)
|
|
2011
|
|
2010
|
||||
$750.0 million fixed rate notes due August 2013, interest equal to 5.40%
|
|
$
|
749.2
|
|
|
$
|
748.6
|
|
$750.0 million fixed rate notes due February 2014, interest equal to 5.75%
|
|
748.0
|
|
|
747.1
|
|
||
$612.5 million fixed rate notes due March 2018, interest equal to 4.40%
(2)
|
|
609.6
|
|
|
609.1
|
|
||
Total long-term debt
|
|
$
|
2,106.8
|
|
|
$
|
2,104.8
|
|
(2)
|
In February 2010, the company entered into a forward-starting interest rate swap agreement that modified the interest obligation associated with these notes so that the interest payable on the notes effectively became fixed at a rate of
4.46%
at issuance on March 18, 2010.
|
(in millions)
|
|
||
2012
|
$
|
—
|
|
2013
|
750.0
|
|
|
2014
|
750.0
|
|
|
2015
|
—
|
|
|
2016
|
—
|
|
|
Thereafter
|
612.5
|
|
(in millions)
|
|
Fair Value
|
||
$750.0 million fixed rate notes due August 2013
|
|
$
|
799.4
|
|
$750.0 million fixed rate notes due February 2014
|
|
818.8
|
|
|
$612.5 million fixed rate notes due March 2018
|
|
673.6
|
|
(in millions)
|
|
2011
|
|
2010
|
|
2009
|
||||||
Income before income taxes:
|
|
|
|
|
|
|
||||||
Domestic
|
|
$
|
1,952.6
|
|
|
$
|
1,733.0
|
|
|
$
|
1,438.0
|
|
Foreign
|
|
(16.1
|
)
|
|
(11.1
|
)
|
|
(0.5
|
)
|
|||
Total
|
|
$
|
1,936.5
|
|
|
$
|
1,721.9
|
|
|
$
|
1,437.5
|
|
Income tax provision:
|
|
|
|
|
|
|
||||||
Current:
|
|
|
|
|
|
|
||||||
Federal
|
|
$
|
644.0
|
|
|
$
|
601.6
|
|
|
$
|
536.9
|
|
State
|
|
135.4
|
|
|
148.9
|
|
|
126.5
|
|
|||
Foreign
|
|
1.4
|
|
|
(3.0
|
)
|
|
5.2
|
|
|||
Total
|
|
780.8
|
|
|
747.5
|
|
|
668.6
|
|
|||
Deferred:
|
|
|
|
|
|
|
||||||
Federal
|
|
300.2
|
|
|
(53.9
|
)
|
|
9.3
|
|
|||
State
|
|
(954.1
|
)
|
|
76.1
|
|
|
(58.4
|
)
|
|||
Foreign
|
|
(4.8
|
)
|
|
0.1
|
|
|
(7.8
|
)
|
|||
Total
|
|
(658.7
|
)
|
|
22.3
|
|
|
(56.9
|
)
|
|||
Total Income Tax Provision
|
|
$
|
122.1
|
|
|
$
|
769.8
|
|
|
$
|
611.7
|
|
|
|
2011
|
|
2010
|
|
2009
|
|||
Statutory U.S. federal tax rate
|
|
35.0
|
%
|
|
35.0
|
%
|
|
35.0
|
%
|
State taxes, net of federal benefit
|
|
6.3
|
|
|
5.8
|
|
|
5.7
|
|
Increase (decrease) in domestic valuation allowance
|
|
(2.5
|
)
|
|
(0.1
|
)
|
|
4.5
|
|
Impact of revised state and local apportionment estimates
|
|
(33.4
|
)
|
|
3.0
|
|
|
(2.7
|
)
|
Other, net
|
|
0.9
|
|
|
1.0
|
|
|
0.1
|
|
Effective Tax Rate
|
|
6.3
|
%
|
|
44.7
|
%
|
|
42.6
|
%
|
(in millions)
|
|
2011
|
|
2010
|
||||
Net Current Deferred Tax Assets:
|
|
|
|
|
||||
Unrealized loss on securities
|
|
$
|
3.5
|
|
|
$
|
3.5
|
|
Stock-based compensation
|
|
12.9
|
|
|
4.4
|
|
||
Accrued expenses and other
|
|
15.6
|
|
|
10.4
|
|
||
Net Current Deferred Tax Assets
|
|
$
|
32.0
|
|
|
$
|
18.3
|
|
Net Non-Current Deferred Tax Assets:
|
|
|
|
|
||||
Domestic unrealized loss on investment in BM&FBOVESPA
|
|
$
|
37.8
|
|
|
$
|
145.8
|
|
Foreign losses
|
|
44.6
|
|
|
146.3
|
|
||
Stock-based compensation
|
|
40.0
|
|
|
42.6
|
|
||
Deferred compensation
|
|
20.3
|
|
|
13.0
|
|
||
Unrealized loss on securities
|
|
46.4
|
|
|
45.9
|
|
||
Accrued expenses and other
|
|
46.4
|
|
|
42.9
|
|
||
Subtotal
|
|
235.5
|
|
|
436.5
|
|
||
Valuation allowance
|
|
(43.2
|
)
|
|
(258.4
|
)
|
||
Total non-current deferred tax assets
|
|
192.3
|
|
|
178.1
|
|
||
Non-Current Deferred Tax Liabilities:
|
|
|
|
|
||||
Purchased intangible assets
|
|
(7,342.0
|
)
|
|
(7,957.8
|
)
|
||
Property
|
|
(77.1
|
)
|
|
(60.7
|
)
|
||
Total non-current deferred tax liabilities
|
|
(7,419.1
|
)
|
|
(8,018.5
|
)
|
||
Net Non-Current Deferred Tax Liabilities
|
|
$
|
(7,226.8
|
)
|
|
$
|
(7,840.4
|
)
|
(in millions)
|
|
2011
|
|
2010
|
|
2009
|
||||||
Gross unrecognized tax benefits
|
|
$
|
36.8
|
|
|
$
|
56.4
|
|
|
$
|
42.6
|
|
Unrecognized tax benefits, net of tax impacts in other jurisdictions
|
|
24.9
|
|
|
43.0
|
|
|
33.5
|
|
|||
Interest and penalties related to uncertain tax positions
|
|
17.1
|
|
|
15.5
|
|
|
8.7
|
|
|||
Interest and penalties recognized in the consolidated statements of income
|
|
1.6
|
|
|
5.4
|
|
|
2.4
|
|
(in millions)
|
|
2011
|
|
2010
|
|
2009
|
||||||
Balance at January 1
|
|
$
|
56.4
|
|
|
$
|
42.6
|
|
|
$
|
21.5
|
|
Unrecognized tax benefits acquired at dates of mergers
|
|
—
|
|
|
—
|
|
|
9.7
|
|
|||
Additions based on tax positions related to the current year
|
|
6.0
|
|
|
10.4
|
|
|
6.7
|
|
|||
Additions for tax positions of prior years
|
|
0.6
|
|
|
4.1
|
|
|
8.1
|
|
|||
Reductions for tax positions of prior years
|
|
(22.9
|
)
|
|
(0.5
|
)
|
|
(1.2
|
)
|
|||
Reductions resulting from the lapse of statutes of limitations
|
|
—
|
|
|
(0.2
|
)
|
|
—
|
|
|||
Settlements with taxing authorities
|
|
(3.3
|
)
|
|
—
|
|
|
(2.2
|
)
|
|||
Balance at December 31
|
|
$
|
36.8
|
|
|
$
|
56.4
|
|
|
$
|
42.6
|
|
(in millions)
|
|
2011
|
|
2010
|
||||
Balance at January 1
|
|
$
|
118.2
|
|
|
$
|
107.5
|
|
Service cost
|
|
13.5
|
|
|
11.6
|
|
||
Interest cost
|
|
7.4
|
|
|
6.5
|
|
||
Actuarial (gain) loss
|
|
14.4
|
|
|
(3.0
|
)
|
||
Benefits paid
|
|
(4.7
|
)
|
|
(4.4
|
)
|
||
Balance at December 31
|
|
$
|
148.8
|
|
|
$
|
118.2
|
|
(in millions)
|
|
2011
|
|
2010
|
|
2009
|
||||||
Balance at January 1
|
|
$
|
121.3
|
|
|
$
|
107.7
|
|
|
$
|
93.8
|
|
Actual return on plan assets
|
|
4.5
|
|
|
12.8
|
|
|
10.7
|
|
|||
Employer contributions
|
|
28.0
|
|
|
5.2
|
|
|
8.5
|
|
|||
Benefits paid
|
|
(4.7
|
)
|
|
(4.4
|
)
|
|
(5.3
|
)
|
|||
Balance at December 31
|
|
$
|
149.1
|
|
|
$
|
121.3
|
|
|
$
|
107.7
|
|
(in millions)
|
|
2011
|
|
2010
|
||||
Level 2:
|
|
|
|
|
||||
Money market funds
|
|
$
|
29.3
|
|
|
$
|
12.4
|
|
Mutual funds:
|
|
|
|
|
||||
U.S. equity
|
|
35.3
|
|
|
31.7
|
|
||
Foreign equity
|
|
33.3
|
|
|
31.5
|
|
||
Fixed income
|
|
45.3
|
|
|
39.9
|
|
||
Commodity
|
|
5.9
|
|
|
5.8
|
|
||
Total
|
|
$
|
149.1
|
|
|
$
|
121.3
|
|
(in millions)
|
|
2011
|
|
2010
|
|
2009
|
||||||
Components of Net Pension Expense:
|
|
|
|
|
|
|
||||||
Service cost
|
|
$
|
13.5
|
|
|
$
|
11.6
|
|
|
$
|
9.7
|
|
Interest cost
|
|
7.4
|
|
|
6.5
|
|
|
5.9
|
|
|||
Expected return on plan assets
|
|
(9.0
|
)
|
|
(8.3
|
)
|
|
(7.0
|
)
|
|||
Recognized net actuarial loss
|
|
1.5
|
|
|
2.2
|
|
|
2.7
|
|
|||
Net Pension Expense
|
|
$
|
13.4
|
|
|
$
|
12.0
|
|
|
$
|
11.3
|
|
Assumptions Used to Determine End-of-Year Benefit Obligation:
|
|
|
|
|
|
|
||||||
Discount rate
|
|
5.00
|
%
|
|
5.70
|
%
|
|
5.70
|
%
|
|||
Rate of compensation increase
|
|
5.00
|
|
|
5.00
|
|
|
5.00
|
|
|||
Cash balance interest crediting rate
|
|
4.00
|
|
|
4.00
|
|
|
4.00
|
|
|||
Assumptions Used to Determine Net Pension Expense:
|
|
|
|
|
|
|
||||||
Discount rate
|
|
5.70
|
%
|
|
5.70
|
%
|
|
6.10
|
%
|
|||
Rate of compensation increase
|
|
5.00
|
|
|
5.00
|
|
|
5.00
|
|
|||
Expected return on plan assets
|
|
7.75
|
|
|
8.00
|
|
|
8.00
|
|
|||
Interest crediting rate
|
|
4.00
|
|
|
4.00
|
|
|
4.00
|
|
|
2011
|
|
2010
|
||
Fixed income
|
30.4
|
%
|
|
32.9
|
%
|
U.S. equity
|
23.6
|
|
|
26.1
|
|
Foreign equity
|
22.3
|
|
|
26.0
|
|
Money market funds
|
19.7
|
|
|
10.2
|
|
Commodity
|
4.0
|
|
|
4.8
|
|
|
Minimum
|
|
Maximum
|
||
U.S. equity
|
23.5
|
%
|
|
35.0
|
%
|
Foreign equity
|
23.5
|
|
|
35.0
|
|
Fixed income
|
33.0
|
|
|
45.0
|
|
Commodity
|
2.0
|
|
|
8.0
|
|
(in millions)
|
|
Prior
Service
Costs
|
|
Actuarial
Loss
|
||||
Balance at January 1
|
|
$
|
0.2
|
|
|
$
|
25.9
|
|
Unrecognized loss
|
|
—
|
|
|
18.9
|
|
||
Recognized as a component of net pension expense
|
|
—
|
|
|
1.5
|
|
||
Balance at December 31
|
|
$
|
0.2
|
|
|
$
|
46.3
|
|
(in millions)
|
|
Year
|
||
2012
|
|
$
|
10.2
|
|
2013
|
|
10.9
|
|
|
2014
|
|
11.6
|
|
|
2015
|
|
12.5
|
|
|
2016
|
|
13.9
|
|
|
2017-2021
|
|
85.4
|
|
•
|
In
July 2008,
the company renegotiated the operating lease for its headquarters at 20 South Wacker Drive in Chicago. The lease, which has an initial term ending on
November 30, 2022
, contains
two
consecutive renewal options for
seven
and
ten
years and a contraction option which allows the company to reduce its occupied space after
|
•
|
In
August 2006
, CME Group entered into an operating lease for additional office space in Chicago. The initial lease term, which became effective on
August 10, 2006
, terminates on
November 30, 2023
. The lease contains
two
5
-year renewal options beginning in
2023.
|
•
|
In
May 1995
, NYMEX Holdings signed a ground lease, which terminates in
June 2069
, with Battery Park City Authority (BPCA) for the site where it constructed its headquarters and trading facility. The lease contains an option to terminate without penalty in June 2012. The lease establishes payments in lieu of taxes (PILOTs) due to New York City. PILOTs are entirely abated until
May 17, 2015
for the trading floor of the facility.
|
•
|
In
January 2011,
the company entered into an operating lease for office space in London. The initial lease term, which became effective on
January 20, 2011
, terminates on
March 24, 2026
, with an option to terminate without penalty in
January 2021
.
|
Year
|
|
||
2012
|
$
|
22.1
|
|
2013
|
25.8
|
|
|
2014
|
25.1
|
|
|
2015
|
22.7
|
|
|
2016
|
22.8
|
|
|
Thereafter
|
135.6
|
|
|
Total
|
$
|
254.1
|
|
Year
|
|
||
2012
|
$
|
5.8
|
|
2013
|
0.4
|
|
|
2014
|
0.4
|
|
|
2015
|
0.4
|
|
|
2016
|
0.3
|
|
|
Thereafter
|
—
|
|
|
Total
|
$
|
7.3
|
|
|
|
Gains (Losses)
Recognized in OCI
(Effective Portion)
|
|
Gains (Losses) Reclassified from
Accumulated OCI (Effective Portion)
|
|
Gains (Losses) Recognized in Income
(Ineffective Portion)
|
||||||||||||||||||||||
(in millions)
|
|
2011
|
|
2010
|
|
Location
|
|
2011
|
|
2010
|
|
Location
|
|
2011
|
|
2010
|
||||||||||||
Contract Type:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest rate contracts
|
|
$
|
—
|
|
|
$
|
(9.7
|
)
|
|
Interest and other borrowing costs
|
|
$
|
(0.5
|
)
|
|
$
|
(20.0
|
)
|
|
Gains (losses) on derivative investments
|
|
$
|
(0.1
|
)
|
|
$
|
(8.6
|
)
|
Foreign exchange contracts
|
|
—
|
|
|
—
|
|
|
Gains (losses) on derivative investments
|
|
—
|
|
|
—
|
|
|
Gains (losses) on derivative investments
|
|
—
|
|
|
6.0
|
|
||||||
Total Derivatives
|
|
$
|
—
|
|
|
$
|
(9.7
|
)
|
|
|
|
$
|
(0.5
|
)
|
|
$
|
(20.0
|
)
|
|
|
|
$
|
(0.1
|
)
|
|
$
|
(2.6
|
)
|
(in millions)
|
|
2011
|
|
2010
|
||||
Balance at January 1
|
|
$
|
68.1
|
|
|
$
|
—
|
|
Contribution by Dow Jones
|
|
—
|
|
|
675.0
|
|
||
Distribution to Dow Jones
|
|
—
|
|
|
(607.5
|
)
|
||
Allocation of stock-based compensation
|
|
0.1
|
|
|
—
|
|
||
Total comprehensive income attributable to redeemable non-controlling interest
|
|
2.1
|
|
|
0.6
|
|
||
Balance at December 31
|
|
$
|
70.3
|
|
|
$
|
68.1
|
|
|
|
December 31,
|
||
(in thousands)
|
|
2011
|
|
2010
|
Class A common stock authorized
|
|
1,000,000
|
|
1,000,000
|
Class A common stock issued and outstanding
|
|
66,128
|
|
66,847
|
Class B-1 common stock authorized, issued and outstanding
|
|
0.6
|
|
0.6
|
Class B-2 common stock authorized, issued and outstanding
|
|
0.8
|
|
0.8
|
Class B-3 common stock authorized, issued and outstanding
|
|
1.3
|
|
1.3
|
Class B-4 common stock authorized, issued and outstanding
|
|
0.4
|
|
0.4
|
(in millions)
|
|
2011
|
|
2010
|
|
2009
|
||||||
Compensation expense
|
|
$
|
51.3
|
|
|
$
|
40.9
|
|
|
$
|
33.4
|
|
Income tax benefit recognized
|
|
18.8
|
|
|
16.4
|
|
|
13.4
|
|
|
Grant Year
|
||||
|
2011
|
|
2010
|
|
2009
|
Dividend yield
|
1.2%-2.4%
|
|
1.4%-1.7%
|
|
1.4%-2.4%
|
Expected volatility
|
41%-42%
|
|
42%-44%
|
|
45%-49%
|
Risk-free interest rate
|
2.0%-2.3%
|
|
1.9%-2.9%
|
|
2.4%-3.2%
|
Expected life
|
5.6 to 6.2 years
|
|
6.2 years
|
|
6.2 to 6.5 years
|
|
|
Number of Shares
|
|
Weighted
Average
Exercise
Price
|
|
Weighted Average Remaining Contractual Life
|
|
Aggregate Intrinsic Value
|
|||||
Outstanding at December 31, 2010
|
|
1,217,121
|
|
|
$
|
307
|
|
|
6.6 years
|
|
$
|
78.8
|
|
Granted
|
|
273,916
|
|
|
272
|
|
|
|
|
|
|||
Exercised
|
|
(34,007
|
)
|
|
169
|
|
|
|
|
|
|||
Cancelled
|
|
(39,814
|
)
|
|
373
|
|
|
|
|
|
|||
Outstanding at December 31, 2011
|
|
1,417,216
|
|
|
302
|
|
|
6.4 years
|
|
29.1
|
|
||
Exercisable at December 31, 2011
|
|
777,232
|
|
|
306
|
|
|
4.6 years
|
|
28.6
|
|
|
Number of Shares
|
|
Weighted
Average
Grant Date
Fair Value
|
|||
Outstanding at December 31, 2010
|
196,830
|
|
|
$
|
283
|
|
Granted
|
157,391
|
|
|
270
|
|
|
Vested
|
(42,677
|
)
|
|
286
|
|
|
Cancelled
|
(25,022
|
)
|
|
285
|
|
|
Outstanding at December 31, 2011
|
286,522
|
|
|
283
|
|
(in millions)
|
|
Net
Unrealized
Gain (Loss)
On Securities
|
|
Change
In
Derivative
Instruments
|
|
Actuarial
Gain (Loss)
on Defined
Benefit Plans
|
|
Foreign
Currency
Translation
Adjustment
|
|
Accumulated
Other
Comprehensive
Income (Loss)
|
||||||||||
Balance at December 31, 2008
|
|
$
|
(25.0
|
)
|
|
$
|
(20.8
|
)
|
|
$
|
(19.6
|
)
|
|
$
|
(94.9
|
)
|
|
$
|
(160.3
|
)
|
Foreign currency translation adjustment
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2.6
|
|
|
2.6
|
|
|||||
Net unrealized gain on securities
|
|
11.8
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11.8
|
|
|||||
Reclassification of security impairment
|
|
13.6
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
13.6
|
|
|||||
Net actuarial loss
|
|
—
|
|
|
—
|
|
|
(1.6
|
)
|
|
—
|
|
|
(1.6
|
)
|
|||||
Amortization of net actuarial loss
|
|
—
|
|
|
—
|
|
|
0.2
|
|
|
—
|
|
|
0.2
|
|
|||||
Net unrealized loss on cash flow hedge
|
|
—
|
|
|
(5.2
|
)
|
|
—
|
|
|
—
|
|
|
(5.2
|
)
|
|||||
Reclassification of realized loss on cash flow hedge
|
|
—
|
|
|
12.7
|
|
|
—
|
|
|
—
|
|
|
12.7
|
|
|||||
Balance at December 31, 2009
|
|
0.4
|
|
|
(13.3
|
)
|
|
(21.0
|
)
|
|
(92.3
|
)
|
|
(126.2
|
)
|
|||||
Foreign currency translation adjustment
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(0.5
|
)
|
|
(0.5
|
)
|
|||||
Net unrealized gain on securities
|
|
6.0
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6.0
|
|
|||||
Reclassification of gain on sale of security
|
|
(0.7
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(0.7
|
)
|
|||||
Net actuarial gain
|
|
—
|
|
|
—
|
|
|
4.5
|
|
|
—
|
|
|
4.5
|
|
|||||
Amortization of net actuarial loss
|
|
—
|
|
|
—
|
|
|
1.3
|
|
|
—
|
|
|
1.3
|
|
|||||
Net unrealized loss on cash flow hedge
|
|
—
|
|
|
(5.8
|
)
|
|
—
|
|
|
—
|
|
|
(5.8
|
)
|
|||||
Ineffectiveness on cash flow hedge
|
|
—
|
|
|
5.2
|
|
|
—
|
|
|
—
|
|
|
5.2
|
|
|||||
Reclassification of realized loss on cash flow hedge
|
|
—
|
|
|
12.1
|
|
|
—
|
|
|
—
|
|
|
12.1
|
|
|||||
Balance at December 31, 2010
|
|
5.7
|
|
|
(1.8
|
)
|
|
(15.2
|
)
|
|
(92.8
|
)
|
|
(104.1
|
)
|
|||||
Foreign currency translation adjustment
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1.6
|
|
|
1.6
|
|
|||||
Reversal of unrealized loss attributable to foreign currency translation
|
|
—
|
|
|
—
|
|
|
—
|
|
|
81.7
|
|
|
81.7
|
|
|||||
Net unrealized gain on securities
|
|
142.7
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
142.7
|
|
|||||
Net actuarial loss
|
|
—
|
|
|
—
|
|
|
(11.9
|
)
|
|
—
|
|
|
(11.9
|
)
|
|||||
Amortization of net actuarial loss
|
|
—
|
|
|
—
|
|
|
1.0
|
|
|
—
|
|
|
1.0
|
|
|||||
Ineffectiveness on cash flow hedge
|
|
—
|
|
|
0.1
|
|
|
—
|
|
|
—
|
|
|
0.1
|
|
|||||
Reclassification of realized loss on cash flow hedge
|
|
—
|
|
|
0.5
|
|
|
—
|
|
|
—
|
|
|
0.5
|
|
|||||
Balance at December 31, 2011
|
|
$
|
148.4
|
|
|
$
|
(1.2
|
)
|
|
$
|
(26.1
|
)
|
|
$
|
(9.5
|
)
|
|
$
|
111.6
|
|
|
|
December 31, 2011
|
||||||||||||||
(in millions)
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
Assets at Fair Value:
|
|
|
|
|
|
|
|
|
||||||||
Marketable securities:
|
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury securities
|
|
$
|
5.1
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
5.1
|
|
Mutual funds
|
|
31.8
|
|
|
—
|
|
|
—
|
|
|
31.8
|
|
||||
Municipal bonds
|
|
—
|
|
|
4.5
|
|
|
—
|
|
|
4.5
|
|
||||
Asset-backed securities
|
|
—
|
|
|
0.9
|
|
|
—
|
|
|
0.9
|
|
||||
U.S. Government agency securities
|
|
—
|
|
|
5.3
|
|
|
—
|
|
|
5.3
|
|
||||
Total
|
|
36.9
|
|
|
10.7
|
|
|
—
|
|
|
47.6
|
|
||||
Equity investments
|
|
552.8
|
|
|
—
|
|
|
—
|
|
|
552.8
|
|
||||
Total Assets at Fair Value
|
|
$
|
589.7
|
|
|
$
|
10.7
|
|
|
$
|
—
|
|
|
$
|
600.4
|
|
Liabilities at Fair Value:
|
|
|
|
|
|
|
|
|
||||||||
Contingent consideration
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
10.3
|
|
|
$
|
10.3
|
|
Total Liabilities at Fair Value
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
10.3
|
|
|
$
|
10.3
|
|
|
|
December 31, 2010
|
||||||||||||||
(in millions)
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
Assets at Fair Value:
|
|
|
|
|
|
|
|
|
||||||||
Marketable securities:
|
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury securities
|
|
$
|
5.1
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
5.1
|
|
Mutual funds
|
|
28.8
|
|
|
—
|
|
|
—
|
|
|
28.8
|
|
||||
Corporate bonds
|
|
—
|
|
|
0.1
|
|
|
—
|
|
|
0.1
|
|
||||
Municipal bonds
|
|
—
|
|
|
4.3
|
|
|
—
|
|
|
4.3
|
|
||||
Asset-backed securities
|
|
—
|
|
|
2.1
|
|
|
—
|
|
|
2.1
|
|
||||
U.S. Government agency securities
|
|
—
|
|
|
9.8
|
|
|
—
|
|
|
9.8
|
|
||||
Total
|
|
33.9
|
|
|
16.3
|
|
|
—
|
|
|
50.2
|
|
||||
Equity investments
|
|
46.0
|
|
|
—
|
|
|
—
|
|
|
46.0
|
|
||||
Total Assets at Fair Value
|
|
$
|
79.9
|
|
|
$
|
16.3
|
|
|
$
|
—
|
|
|
$
|
96.2
|
|
Liabilities at Fair Value:
|
|
|
|
|
|
|
|
|
||||||||
Interest rate swap contracts
|
|
$
|
—
|
|
|
$
|
11.8
|
|
|
$
|
—
|
|
|
$
|
11.8
|
|
Contingent consideration
|
|
—
|
|
|
—
|
|
|
9.5
|
|
|
9.5
|
|
||||
Total Liabilities at Fair Value
|
|
$
|
—
|
|
|
$
|
11.8
|
|
|
$
|
9.5
|
|
|
$
|
21.3
|
|
(in millions)
|
Contingent Consideration
|
||
Fair value of liability at January 1, 2010
|
$
|
—
|
|
Contingent obligation arising from acquisition
|
9.5
|
|
|
Fair value of liability at December 31, 2010
|
9.5
|
|
|
Realized and unrealized gains (losses):
|
|
||
Included in operating expense
|
0.8
|
|
|
Fair value of liability at December 31, 2011
|
$
|
10.3
|
|
|
2011
|
|
2010
|
|
2009
|
||||||
Net Income Attributable to CME Group (in millions)
|
$
|
1,812.3
|
|
|
$
|
951.4
|
|
|
$
|
825.8
|
|
Weighted Average Common Shares Outstanding (in thousands):
|
|
|
|
|
|
||||||
Basic
|
66,547
|
|
|
66,299
|
|
|
66,366
|
|
|||
Effect of stock options and restricted stock awards
|
215
|
|
|
196
|
|
|
182
|
|
|||
Diluted
|
66,762
|
|
|
66,495
|
|
|
66,548
|
|
|||
Earnings per Common Share Attributable to CME Group:
|
|
|
|
|
|
||||||
Basic
|
$
|
27.23
|
|
|
$
|
14.35
|
|
|
$
|
12.44
|
|
Diluted
|
27.15
|
|
|
14.31
|
|
|
12.41
|
|
(in millions, except per share data)
|
|
First
Quarter
|
|
Second
Quarter
|
|
Third
Quarter
|
|
Fourth
Quarter
|
|
Total
|
||||||||||
Year Ended December 31, 2011
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Total revenues
|
|
$
|
831.6
|
|
|
$
|
838.3
|
|
|
$
|
874.2
|
|
|
$
|
736.5
|
|
|
$
|
3,280.6
|
|
Operating income
|
|
524.1
|
|
|
534.5
|
|
|
572.1
|
|
|
390.4
|
|
|
2,021.1
|
|
|||||
Non-operating income (expense)
|
|
(12.5
|
)
|
|
(25.2
|
)
|
|
(26.2
|
)
|
|
(20.7
|
)
|
|
(84.6
|
)
|
|||||
Income before income taxes
|
|
511.6
|
|
|
509.3
|
|
|
545.9
|
|
|
369.7
|
|
|
1,936.5
|
|
|||||
Net income attributable to CME Group
|
|
456.6
|
|
|
293.7
|
|
|
316.1
|
|
|
745.9
|
|
|
1,812.3
|
|
|||||
Earnings per common share attributable to CME Group:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
|
$
|
6.83
|
|
|
$
|
4.40
|
|
|
$
|
4.76
|
|
|
$
|
11.28
|
|
|
$
|
27.23
|
|
Diluted
|
|
6.81
|
|
|
4.38
|
|
|
4.74
|
|
|
11.25
|
|
|
27.15
|
|
|||||
Year Ended December 31, 2010
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Total revenues
|
|
$
|
693.2
|
|
|
$
|
813.9
|
|
|
$
|
733.4
|
|
|
$
|
763.2
|
|
|
$
|
3,003.7
|
|
Operating income
|
|
414.7
|
|
|
515.1
|
|
|
442.9
|
|
|
458.4
|
|
|
1,831.1
|
|
|||||
Non-operating income (expense)
|
|
(15.8
|
)
|
|
(35.0
|
)
|
|
(27.2
|
)
|
|
(31.2
|
)
|
|
(109.2
|
)
|
|||||
Income before income taxes
|
|
398.9
|
|
|
480.1
|
|
|
415.7
|
|
|
427.2
|
|
|
1,721.9
|
|
|||||
Net income attributable to CME Group
|
|
240.2
|
|
|
270.7
|
|
|
244.3
|
|
|
196.2
|
|
|
951.4
|
|
|||||
Earnings per common share attributable to CME Group:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
|
$
|
3.63
|
|
|
$
|
4.13
|
|
|
$
|
3.67
|
|
|
$
|
2.94
|
|
|
$
|
14.35
|
|
Diluted
|
|
3.62
|
|
|
4.11
|
|
|
3.66
|
|
|
2.93
|
|
|
14.31
|
|
ITEM 9.
|
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
|
ITEM 9A.
|
CONTROLS AND PROCEDURES
|
ITEM 9B.
|
OTHER INFORMATION
|
ITEM 10.
|
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
|
ITEM 11.
|
EXECUTIVE COMPENSATION
|
ITEM 12.
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS
|
ITEM 13.
|
CERTAIN RELATIONSHIPS, RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE
|
ITEM 14.
|
PRINCIPAL ACCOUNTANT FEES AND SERVICES
|
ITEM 15.
|
EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
|
|
Balance at
beginning
of year
|
|
Charged
against
goodwill
|
|
Charged
(credited) to
costs and
expenses
|
|
Other
(1)
|
|
Balance
at end
of year
|
||||||||||
Year Ended December 31, 2011
|
|
|
|
|
|
|
|
|
|
||||||||||
Allowance for doubtful accounts
|
$
|
1.6
|
|
|
$
|
—
|
|
|
$
|
22.4
|
|
|
$
|
(22.7
|
)
|
|
$
|
1.3
|
|
Allowance for deferred tax assets
|
258.4
|
|
|
—
|
|
|
(46.4
|
)
|
|
(168.8
|
)
|
|
43.2
|
|
|||||
Year Ended December 31, 2010
|
|
|
|
|
|
|
|
|
|
||||||||||
Allowance for doubtful accounts
|
$
|
1.9
|
|
|
$
|
—
|
|
|
$
|
0.2
|
|
|
$
|
(0.5
|
)
|
|
$
|
1.6
|
|
Allowance for deferred tax assets
|
264.4
|
|
|
—
|
|
|
(6.1
|
)
|
|
0.1
|
|
|
258.4
|
|
|||||
Year Ended December 31, 2009
|
|
|
|
|
|
|
|
|
|
||||||||||
Allowance for doubtful accounts
|
$
|
1.8
|
|
|
$
|
—
|
|
|
$
|
1.4
|
|
|
$
|
(1.3
|
)
|
|
$
|
1.9
|
|
Allowance for deferred tax assets
|
168.3
|
|
|
24.5
|
|
|
71.6
|
|
|
—
|
|
|
264.4
|
|
(1)
|
Includes write-offs of doubtful accounts and reversals of deferred tax asset valuation allowances against accumulated other comprehensive income.
|
(3)
|
Exhibits
|
Exhibit
Number
|
|
Description of Exhibit
|
|
|
|
2.
|
|
Plan of Acquisition, Reorganization, Arrangement, Liquidation or Succession
|
|
|
|
2.1
|
|
Agreement and Plan of Merger, dated as of October 1, 2001, between Chicago Mercantile Exchange Inc., Chicago Mercantile Exchange Holdings Inc. and CME Merger Subsidiary Inc. (incorporated by reference to Exhibit 2.1 to Chicago Mercantile Exchange Holdings Inc.’s Form S-4, filed with the SEC on August 7, 2001, File No. 333-66988).
|
|
|
|
2.2
|
|
Agreement and Plan of Merger, dated as of October 17, 2006, among Chicago Mercantile Exchange Holdings Inc., CBOT Holdings, Inc. and Board of Trade of the City of Chicago, Inc. (incorporated by reference to Exhibit 2.1 to Chicago Mercantile Exchange Holdings Inc.’s Form 8-K, filed with the SEC on October 19, 2006, File No. 000-33379); Amendment, dated as of May 11, 2007 (incorporated by reference to Exhibit 2.1 to Chicago Mercantile Exchange Holdings Inc.’s Form 8-K, filed with the SEC on May 11, 2007, File No. 000-33379); Amendment, dated as of June 14, 2007 (incorporated by reference to Exhibit 2.1 to Chicago Mercantile Exchange Holdings Inc.’s Form 8-K, filed with the SEC on June 14, 2007, File No. 000-33379); Amendment, dated as of July 6, 2007 (incorporated by reference to Exhibit 2.1 to CME Group Inc.’s Form 8-K, filed with SEC on July 6, 2007, File No. 000-33379).
|
|
|
|
2.3
|
|
Agreement and Plan of Merger, dated as of March 17, 2008, among CME Group Inc., CMEG NY Inc., NYMEX Holdings, Inc. and New York Mercantile Exchange, Inc. (incorporated by reference to Exhibit 2.1 to CME Group Inc.’s Form 8-K, filed with the SEC on March 21, 2008, File No. 000-33379); Amendment, dated June 30, 2008 (incorporated by reference to Exhibit 2.1 to CME Group Inc.’s Form 10-Q, filed with the SEC on August 7, 2008, File No. 001-31553); Amendment, dated as of July 18, 2008 (incorporated by reference to Exhibit 2.1 to CME Group’s Current Report on Form 8-K, filed with the SEC on July 23, 2008, File No. 001-31553); Amendment, dated as of August 7, 2008 (incorporated by reference to Exhibit No. 2.2 to CME Group’s Form 10-Q filed with the SEC on November 11, 2008, File No. 001-31553).
|
|
|
|
3.
|
|
Articles of Incorporation and Bylaws
|
|
|
|
3.1
|
|
Third Amended and Restated Certificate of Incorporation of CME Group Inc. (incorporated by reference to Exhibit 3.1 to CME Group Inc.’s Current Report on Form 8-K, filed with the SEC on August 28, 2008, File No. 001-31553).
|
|
|
|
3.2
|
|
Seventh Amended and Restated Bylaws of CME Group Inc. (incorporated by reference to Exhibit 3.1 to CME Group Inc.’s Current Report on Form 8-K, filed with the SEC on May 20, 2009, File No. 001-31553).
|
|
|
|
4.
|
|
Instruments Defining the Rights of Security Holders
|
|
|
|
4.1
|
|
Commercial Paper Dealer Agreement, dated as of August 16, 2007, among CME Group Inc., as Issuer, and Merrill Lynch Money Markets Inc., as Dealer, for Notes with maturities up to 270 days, and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as Dealer for Notes with maturities over 270 days (incorporated by reference to Exhibit 4.2 to CME Group Inc.’s Form 10-Q, filed with the SEC on November 8, 2007, File No. 000-33379).
|
|
|
|
4.2
|
|
Issuing and Paying Agency Agreement, dated as of August 16, 2007, between CME Group Inc. and JPMorgan Chase Bank, National Association, as issuing and paying agent (incorporated by reference to Exhibit 4.3 to CME Group Inc.’s Form 10-Q, filed with the SEC on November 8, 2007, File No. 000-33379).
|
|
|
|
4.3
|
|
Commercial Paper Dealer Agreement, dated as of August 20, 2008, between CME Group Inc., as Issuer, and Bank of America Securities LLC, as Dealer (incorporated by reference to Exhibit 10.1 to CME Group Inc.’s Current Report on Form 8-K, filed with the SEC on August 26, 2008, File No. 001-31553).
|
|
|
|
4.4
|
|
Commercial Paper Dealer Agreement, dated as of August 22, 2008, between CME Group Inc., as Issuer, and Goldman, Sachs & Co., as Dealer (incorporated by reference to Exhibit 10.2 to CME Group Inc.’s Current Report on Form 8-K, filed with the SEC on August 26, 2008, File No. 001-31553).
|
|
|
|
4.5
|
|
Indenture, dated August 12, 2008, between CME Group Inc. and U.S. Bank National Association (incorporated by reference to Exhibit 4.1 to CME Group Inc.’s Current Report on Form 8-K, filed with the SEC on August 13, 2008, File No. 001-31553).
|
|
|
|
4.6
|
|
Second Supplemental Indenture (including the form of floating rate note due 2010), dated August 12, 2008, between CME Group Inc. and U.S. Bank National Association (incorporated by reference to Exhibit 4.3 to CME Group Inc.’s Current Report on Form 8-K, filed with the SEC on August 13, 2008, File No. 001-31553).
|
|
|
|
Exhibit
Number
|
|
Description of Exhibit
|
4.7
|
|
Third Supplemental Indenture, dated August 12, 2008 (including the form of 5.4% note due 2013), between CME Group Inc. and U.S. Bank National Association (incorporated by reference to Exhibit 4.4 to CME Group Inc.’s Current Report on Form 8-K, filed with the SEC on August 13, 2008, File No. 001-31553).
|
|
|
|
4.8
|
|
Fourth Supplemental Indenture (including the form of 5.75% note due 2014), dated February 9, 2009, between CME Group Inc. and U.S. Bank National Association (incorporated by reference to Exhibit 4.2 to CME Group Inc.’s Current Report on Form 8-K, filed with the SEC on February 9, 2009, File No. 001-31553).
|
|
|
|
4.9
|
|
Indenture, dated March 18, 2010, between CME Group Index Services LLC, CME Group Inc. and U.S. Bank National Association (incorporated by reference to CME Group Inc.’s Form 8-K, filed with the SEC on March 23, 2010, File No. 001-31553).
|
|
|
|
10.
|
|
Material Contracts
|
|
|
|
10.1(1)
|
|
CME Group Inc. Amended and Restated Omnibus Stock Plan, amended and restated effective as of June 17, 2009 (incorporated by reference to Exhibit 10.3 to CME Group Inc.’s Form 10-Q, filed with the SEC on August 6, 2009, File No. 001-31553).
|
|
|
|
10.2(1)
|
|
Form of Equity Grant Letter for Executive Officers (incorporated by reference to Exhibit 10.2 to CME Group Inc.’s Form 10-K, filed with the SEC on February 26, 2010, File No. 001-31553).
|
|
|
|
10.3(1)
|
|
Form of equity grant letter for performance based shares based on specific Company initiatives (incorporated by reference to Exhibit 10.7 to CME Group Inc.'s Form 10-Q, filed with the SEC on August 5, 2011, File No. 001-31553).
|
|
|
|
10.4(1)
|
|
Form of equity grant letter for annual grant of performance shares (incorporated by reference to Exhibit 10.8 to CME Group Inc.'s Form 10-Q, filed with the SEC on August 5, 2011, File No. 001-31553).
|
|
|
|
10.5(1)
|
|
CME Group Inc. 2005 Director Stock Plan, amended and restated effective as of (incorporated by reference to Exhibit 10.2 to CME Group Inc.'s Current Report on Form 8-K, filed with the SEC on May 18, 2009, File No. 001-31553).
|
|
|
|
10.6(1)
|
|
Form of Equity Stipend Grant Letter for Non-Executive Directors (incorporated by reference to Exhibit 10.4 to CME Group Inc.'s Form 10-K, filed with the SEC on February 26, 2010, File No. 001-31553).
|
|
|
|
10.7(1)
|
|
Chicago Mercantile Exchange Holdings Inc. Amended and Restated Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.1 to CME Group Inc.'s Form 10-Q, filed with the SEC on August 3, 2007, File No. 000-33379) and the First Amendment to the CME Group Inc. Employee Stock Purchase Plan, dated May 6, 2010, (incorporated by reference to Exhibit 10.1 to CME Group Inc.'s Form 10-Q, filed with the SEC on August 6, 2010, File No. 001-31553).
|
|
|
|
10.8(1)
|
|
Amended and Restated CBOT Holdings, Inc. 2005 Long-Term Equity Plan, amended and restated as of December 2, 2008 (incorporated by reference to Exhibit 10.6 to CME Group Inc.'s Form 10-K, filed with the SEC on March 2, 2009, File No. 001-31553).
|
|
|
|
10.9(1)
|
|
Amended and Restated NYMEX Holdings, Inc. 2006 Omnibus Long-Term Incentive Plan, amended and restated as of December 2, 2008 (incorporated by reference to Exhibit 10.7 to CME Group Inc.'s Form 10-K, filed with the SEC on March 2, 2009, File No. 001-31553).
|
|
|
|
10.10(1)
|
|
Chicago Mercantile Exchange Inc. Senior Management Supplemental Deferred Savings Plan (SMSDSP) consisting of the Grandfathered SMSDSP, amended and restated as of January 1, 2008, and the Amended and Restated 409A SMSDSP, amended and restated as of January 1, 2008 (incorporated by reference to Exhibit 10.7 to CME Group Inc.'s Form 10-K, filed with the SEC on February 28, 2008, File No. 000-33379).
|
|
|
|
10.11(1)
|
|
Amended and Restated Chicago Mercantile Exchange Inc. Directors' Deferred Compensation Plan, amended and restated as of January 1, 2009 (incorporated by reference to Exhibit 10.9 to CME Group Inc.'s Form 10-K, filed with the SEC on March 2, 2009, File No. 001-31553).
|
|
|
|
10.12(1)
|
|
NYMEX Holdings, Inc. Executive Deferred Compensation Plan for Key Employees (incorporated by reference to Exhibit 10.5 to NYMEX Holdings, Inc.'s Form 10-K, filed with the SEC on March 29, 2001, File No. 000-1105018).
|
|
|
|
10.13(1)
|
|
Chicago Mercantile Exchange Inc. Supplemental Executive Retirement Plan consisting of the Grandfathered Supplemental Retirement Plan, amended and restated as of January 1, 2008, and the Amended and Restated 409A Supplemental Executive Retirement Plan, amended and restated as of January 1, 2008 (incorporated by reference to Exhibit 10.9 to CME Group Inc.'s Form 10-K, filed with the SEC on February 28, 2008, File No. 000-33379).
|
|
|
|
Exhibit
Number
|
|
Description of Exhibit
|
10.14(1)
|
|
Chicago Mercantile Exchange Inc. Supplemental Executive Retirement Trust; First Amendment thereto, dated September 7, 1993 (incorporated by reference to Exhibit 10.5 to Chicago Mercantile Exchange Inc.'s Form S-4, filed with the SEC on February 24, 2000, File No. 333-95561); Second Amendment to Chicago Mercantile Exchange Inc. Senior Management Supplemental Deferred Savings Plan, executed as of April 25, 2011 (incorporated by reference to Exhibit 10.4 to CME Group Inc.'s Form 10-Q, filed with the SEC on August 5, 2011, File No. 001-31553)
|
|
|
|
10.15(1)
|
|
COMEX Members' Recognition and Retention Plan (incorporated by reference to Exhibit 10.11 to NYMEX Holdings, Inc.'s Form 10-K, filed with the SEC on March 29, 2001, File No. 000-1105018).
|
|
|
|
10.16(1)
|
|
Amended and Restated CME Group Inc. Incentive Plan for Named Executive Officers (incorporated by reference to Exhibit 10.3 to CME Group Inc.'s Current Report on Form 8-K, filed with the SEC on May 18, 2009, File No. 001-31553); Amendment, effective as of February 2, 2010 (incorporated by reference to Exhibit 10.14 to CME Group Inc.'s Form 10-K, filed with the SEC on February 26, 2010, File No. 001-31553); Second Amendment to the Amended and Restated CME Group Inc. Annual Incentive Plan for Named Executive Officers, executed as of April 25, 2011 (incorporated by reference to Exhibit 10.5 to CME Group Inc.'s Form 10-Q, filed with the SEC on August 5, 2011, File No. 001-31553).
|
|
|
|
10.17(1)
|
|
CME Group Inc. Annual Incentive Plan, adopted as of March 4, 2008 (incorporated by reference to Exhibit 10.2 to CME Group Inc.'s Form 10-Q, filed with the SEC on May 9, 2008, File No. 000-33379); Amendment, effective as of February 2, 2010 (incorporated by reference to Exhibit 10.15 to CME Group Inc.'s Form 10-K, filed with the SEC on February 26, 2010, File No. 001-31553); Second Amendment to the Amended and Restated CME Group Inc. Annual Incentive Plan, executed as of April 25, 2011 (incorporated by reference to Exhibit 10.6 to CME Group Inc.'s Form 10-Q, filed with the SEC on August 5, 2011, File No. 001-31553).
|
|
|
|
10.18(1)
|
|
Amended and Restated CME Group Inc. Severance Plan for Corporate Officers, dated as of August 13, 2007 (incorporated by reference to Exhibit 10.9 to CME Group Inc.'s Form 10-Q, filed with the SEC on November 8, 2007, File No. 000-33379); Amendment, effective as of December 21, 2007 (incorporated by reference to Exhibit 10.12 to CME Group Inc.'s Form 10-K, filed with the SEC on February 28, 2008, File No. 000-33379).
|
|
|
|
10.19(1)
|
|
Agreement, dated as of April 14, 2011, between CME Group Inc. and Craig S. Donohue (incorporated by reference to Exhibit 10.2 to CME Group Inc.'s Form 10-Q, filed with the SEC on August 5, 2011, File No. 001-31553).
|
|
|
|
10.20(1)
|
|
Amended and Restated Agreement, dated August 5, 2009, between CME Group Inc. and Phupinder Gill (incorporated by reference to Exhibit 10.2 to CME Group Inc.'s Form 8-K, filed with the SEC on August 6, 2009, File No. 001-31553) Amendment to Employment Agreement, dated April 6, 2011, between CME Group Inc. and Phupinder S. Gill (incorporated by reference to Exhibit 10.3 to CME Group Inc.'s Form 10-Q, filed with the SEC on August 5, 2011, File No. 001-31553);.
|
|
|
|
10.21(1)
|
|
Agreement between CME Group Inc. and Terrence A. Duffy, dated as of November 9, 2010 (incorporated by reference to Exhibit 10.1 to CME Group Inc.'s Form 8-K, filed with the SEC on November 15, 2010, File No. 001-31553); Amendment to Employment Agreement, dated April 6, 2011, between CME Group Inc. and Terrence A. Duffy (incorporated by reference to Exhibit 10.1 to CME Group Inc.'s Form 10-Q, filed with the SEC on August 5, 2011, File No. 001-31553).
|
|
|
|
10.22(1)
|
|
Consulting Agreement between Leo Melamed and CME Group Inc., dated June 26, 2009 (incorporated by reference to Exhibit 10.2 to CME Group Inc.'s Form 10-Q, filed with the SEC on August 6, 2009, File No. 001-31553).
|
|
|
|
10.23(1)
|
|
Consulting Agreement between Leo Melamed and Chicago Mercantile Exchange Holdings Inc., dated November 14, 2005 (incorporated by reference to Exhibit 10.28 to Chicago Mercantile Exchange Holdings Inc.'s Form 10-K filed with the SEC on March 6, 2006, File No. 000-33379).
|
|
|
|
10.24(1)
|
|
Consulting Agreement between Jack Sandner and Chicago Mercantile Exchange Holdings Inc., dated October 10, 2005 (incorporated by reference to Exhibit 10.4 to Chicago Mercantile Exchange Holdings Inc.'s Form 10-Q, filed with the SEC on November 4, 2005, File No. 000-33379).
|
|
|
|
10.25(1)*
|
|
Consulting Agreement between Charles P. Carey and CME Group Inc., dated October 13, 2011.
|
|
|
|
Exhibit
Number
|
|
Description of Exhibit
|
10.26(2)
|
|
Amended and Restated License Agreement, effective as of September 20, 2005, by and between Standard & Poor's, a division of The McGraw-Hill Companies, Inc., and Chicago Mercantile Exchange Inc. (incorporated by reference to Exhibit 10.1 to Chicago Mercantile Exchange Holdings Inc.'s Form 10-Q, filed with the SEC on November 4, 2005, File No. 000-33379); Amendment, dated March 30, 2006 (incorporated by reference to Exhibit 10.3 to Chicago Mercantile Exchange Holdings Inc.'s Form 10-Q, filed with the SEC on May 8, 2006, File No. 000-33379); Amendment, dated September 22, 2006 (incorporated by reference to Exhibit 10.3 to Chicago Mercantile Exchange Holdings Inc.'s Form 10-Q filed with the SEC on November 6, 2006, File No. 000-33379); Amendment, dated September 28, 2006 (incorporated by reference to Exhibit 10.4 to Chicago Mercantile Exchange Holdings Inc.'s Form 10-Q filed with the SEC on November 6, 2006, File No. 000-33379); Amendment, dated as of March 2, 2009 (incorporated by reference to Exhibit 10.1 to CME Group Inc.'s Form 10-Q, filed with the SEC on May 8, 2009, File No. 001-31553); Amendment, dated as of April 27, 2009 (incorporated by reference to Exhibit 10.6 to CME Group Inc.'s Form 10-Q, filed with the SEC on August 6, 2009, File No. 001-31553); Amendment, dated as of April 27, 2009 (incorporated by reference to Exhibit 10.7 to CME Group Inc.'s Form 10-Q, filed with the SEC on August 6, 2009, File No. 001-31553); Amendment, dated as of July 24, 2009, (incorporated by reference to Exhibit 10.5 to CME Group Inc.'s Form 10-Q, filed with the SEC on November 6, 2009, File No. 001-31553); Amendment, dated October 2, 2009 (incorporated by reference to Exhibit 10.26 to CME Group Inc.'s Form 10-K, filed with the SEC on February 26, 2010, File No. 001-31553).
|
|
|
|
10.27(2)
|
|
License Agreement, effective as of October 9, 2003, between The Nasdaq Stock Market, Inc., a subsidiary of National Association of Securities Dealers, Inc., and Chicago Mercantile Exchange Inc. (incorporated by reference to Chicago Mercantile Exchange Holdings Inc.'s Form 10-K, filed with the SEC on March 11, 2004, File No. 001-31553), Amendment, dated April 26, 2005 (incorporated by reference to Exhibit 10.1 to Chicago Mercantile Exchange Holdings Inc.'s Form 10-Q, filed with the SEC on August 4, 2005, File No. 001-31553); Amendment, dated June 22, 2005 (incorporated by reference to Exhibit 10.2 to Chicago Mercantile Exchange Holdings Inc.'s Form 10-Q, filed with the SEC on August 4, 2005, File No. 001-31553); Amendment, dated as of June 26, 2008 (incorporated by reference to Exhibit 10.1 to CME Group Inc.'s Form 10-Q, filed with the SEC on August 7, 2008, File No. 001-31553).
|
|
|
|
10.28
|
|
Credit Agreement, dated as of January 11, 2011 among CME Group Inc. as Borrower, the Lenders party thereto, and Bank of America, N.A., as Administrative Agent, UBS Securities LLC, Barclays Capital, and Wells Fargo Securities, LLC, as Co-Syndication Agents, and Merrill Lynch, Pierce, Fenner & Smith Incorporated, Barclays Capital, UBS Securities LLC, and Wells Fargo Securities, LLC, as Joint Lead Arrangers and Joint Book Managers (incorporated by reference to Exhibit 10.1 to CME Group Inc.'s Form 8-K, filed with the SEC on January 14, 2011, File No. 001-31553); Amendment to Credit Agreement for Commitment Increase, dated as of November 1, 2011, among CME Group Inc., as borrower, JPMorgan Chase Bank, N.A., and Bank of America, as administrative agent (incorporated by reference to Exhibit 10.1 to CME Group Inc.'s Form 8-K, filed with the SEC on November 4, 2011, File No. 001-31553).
|
|
|
|
10.29
|
|
Credit Facility, dated as of November 14, 2011, with each of the banks from time to time party thereto, JPMORGAN CHASE BANK, N.A., as administrative agent and as collateral agent, BANK OF AMERICA, N.A., as syndication agent, BMO HARRIS BANK N.A., as documentation agent, J.P. MORGAN SECURITIES LLC and MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED, as joint lead arrangers (incorporated by reference to Exhibit 10.1 to CME Group Inc.'s Form 8-K, filed with the SEC on November 17, 2011), File No. 001-31553).
|
|
|
|
10.30
|
|
Commercial Paper Dealer Agreement, dated as of August 16, 2007, between CME Group Inc., as Issuer, and Merrill Lynch Money Markets Inc., as Dealer for Notes with maturities up to 270 days and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as Dealer for Notes with maturities over 270 days (incorporated by reference to Exhibit 4.1 above).
|
|
|
|
10.31
|
|
Issuing and Paying Agency Agreement, dated as of August 16, 2007, between CME Group Inc. and JPMorgan Chase Bank, National Association, as issuing and paying agent (incorporated by reference to Exhibit 4.2 above).
|
|
|
|
10.32
|
|
Commercial Paper Dealer Agreement, dated as of August 20, 2008, between CME Group Inc., as Issuer, and Bank of America Securities LLC, as Dealer (incorporated by reference to Exhibit 4.3 above).
|
|
|
|
10.33
|
|
Commercial Paper Dealer Agreement, dated as of August 22, 2008, between CME Group Inc., as Issuer, and Goldman, Sachs & Co., as Dealer (incorporated by reference to Exhibit 4.4 above).
|
|
|
|
10.34
|
|
Ground Lease between Battery Park City Authority and New York Mercantile Exchange dated May 18, 1995 (incorporated by reference to Exhibit 10.3 to NYMEX Holdings, Inc.'s Registration Statement on Form S-4, File No. 333-30332).
|
|
|
|
10.35
|
|
Funding Agreement among New York State Urban Development Corporation, New York City Economic Development Corporation, Battery Park City Authority and New York Mercantile Exchange dated May 18, 1995 (incorporated by reference to Exhibit 10.4 to NYMEX Holdings, Inc.'s Registration Statement on Form S-4, File No. 333-30332).
|
|
|
|
Exhibit
Number
|
|
Description of Exhibit
|
12.1*
|
|
Ratio of Fixed Charges.
|
|
|
|
21.1*
|
|
List of Subsidiaries of CME Group Inc.
|
|
|
|
23.1*
|
|
Consent of Ernst & Young LLP.
|
|
|
|
31.1*
|
|
Section 302—Certification of Craig S. Donohue.
|
|
|
|
31.2*
|
|
Section 302—Certification of James E. Parisi.
|
|
|
|
32.1*
|
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
101.INS*
|
|
XBRL Instance Document
|
|
|
|
101.SCH*
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
101.CAL*
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
101.DEF*
|
|
XBRL Taxonomy Extension Definition Linkbase
|
|
|
|
101.LAB*
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
101.PRE*
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
*
|
Filed herewith.
|
(1)
|
Management contract or compensatory plan or arrangement.
|
(2)
|
Confidential treatment pursuant to Rule 406 of the Securities Act has been previously granted by the SEC for portions of this exhibit.
|
|
CME Group Inc.
|
||
|
|
|
|
|
By:
|
|
/
S
/ J
AMES
E. P
ARISI
|
|
|
|
James E. Parisi
Managing Director and Chief Financial Officer
|
Signature
|
|
Title
|
|
|
|
/
S
/ T
ERRENCE
A. D
UFFY
|
|
Executive Chairman of the Board and Director
|
Terrence A. Duffy
|
|
|
|
|
|
/
S
/ C
RAIG
S. D
ONOHUE
|
|
Chief Executive Officer and Director
|
Craig S. Donohue
|
|
|
|
|
|
/
S
/ J
AMES
E. P
ARISI
|
|
Managing Director and Chief Financial Officer
|
James E. Parisi
|
|
|
|
|
|
/
S
/ J
AMES
V. P
IEPER
|
|
Managing Director and Chief Accounting Officer
|
James V. Pieper
|
|
|
|
|
|
/
S
/ L
EO
M
ELAMED
|
|
Chairman Emeritus and Director
|
Leo Melamed
|
|
|
|
|
|
/
S
/ J
EFFREY
M. B
ERNACCHI
|
|
Director
|
Jeffrey M. Bernacchi
|
|
|
|
|
|
/
S
/ T
IMOTHY
S. B
ITSBERGER
|
|
Director
|
Timothy S. Bitsberger
|
|
|
|
|
|
/
S
/ C
HARLES
P. C
AREY
|
|
Director
|
Charles P. Carey
|
|
|
|
|
|
/
S
/ M
ARK
E. C
ERMAK
|
|
Director
|
Mark E. Cermak
|
|
|
|
|
|
/
S
/ D
ENNIS
H. C
HOOKASZIAN
|
|
Director
|
Dennis H. Chookaszian
|
|
|
|
|
|
/
S
/ J
ACKIE
C
LEGG
|
|
Director
|
Jackie Clegg
|
|
|
|
|
|
/
S
/ R
OBERT
F. C
ORVINO
|
|
Director
|
Robert F. Corvino
|
|
|
|
|
|
/
S
/ J
AMES
A. D
ONALDSON
|
|
Director
|
James A. Donaldson
|
|
|
|
|
|
/
S
/ M
ARTIN
J. G
EPSMAN
|
|
Director
|
Martin J. Gepsman
|
|
|
|
|
|
/
S
/ L
ARRY
G. G
ERDES
|
|
Director
|
Larry G. Gerdes
|
|
|
|
|
|
/
S
/ D
ANIEL
R. G
LICKMAN
|
|
Director
|
Daniel R. Glickman
|
|
|
/
S
/ J. D
ENNIS
H
ASTERT
|
|
Director
|
J. Dennis Hastert
|
|
|
|
|
|
/
S
/ B
RUCE
F. J
OHNSON
|
|
Director
|
Bruce F. Johnson
|
|
|
|
|
|
/
S
/ G
ARY
M. K
ATLER
|
|
Director
|
Gary M. Katler
|
|
|
|
|
|
/
S
/ W
ILLIAM
P. M
ILLER
II
|
|
Director
|
William P. Miller II
|
|
|
|
|
|
/
S
/ JOSEPH NICIFORO
|
|
Director
|
Joseph Niciforo
|
|
|
|
|
|
/
S
/ C.C. O
DOM
II
|
|
Director
|
C.C. Odom II
|
|
|
|
|
|
/
S
/ JAMES E. OLIFF
|
|
Director
|
James E. Oliff
|
|
|
|
|
|
/
S
/ RONALD A. PANKAU
|
|
Director
|
Ronald A. Pankau
|
|
|
|
|
|
/
S
/ J
OHN
L. P
IETRZAK
|
|
Director
|
John L. Pietrzak
|
|
|
|
|
|
/
S
/ EDEMIR PINTO
|
|
Director
|
Edemir Pinto
|
|
|
|
|
|
/
S
/ A
LEX
J. P
OLLOCK
|
|
Director
|
Alex J. Pollock
|
|
|
|
|
|
/
S
/ J
OHN
F. S
ANDNER
|
|
Director
|
John F. Sandner
|
|
|
|
|
|
/
S
/ T
ERRY
L. S
AVAGE
|
|
Director
|
Terry L. Savage
|
|
|
|
|
|
/
S
/ W
ILLIAM
R. S
HEPARD
|
|
Director
|
William R. Shepard
|
|
|
|
|
|
/
S
/ H
OWARD
J. S
IEGEL
|
|
Director
|
Howard J. Siegel
|
|
|
|
|
|
/
S
/ C
HRISTOPHER
S
TEWART
|
|
Director
|
Christopher Stewart
|
|
|
|
|
|
/
S
/ D
ENNIS
A. S
USKIND
|
|
Director
|
Dennis A. Suskind
|
|
|
|
|
|
/
S
/ D
AVID
J. W
ESCOTT
|
|
Director
|
David J. Wescott
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
No Suppliers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|